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Zusammenfassung 
 
In der vorliegenden Arbeit wird der molekulare Mechanismus der Fusion lytischer 
Granulen (LG) mit der Plasmamembran in cytotoxischen T Lymphocyten (CTL) 
untersucht. Im Speziellen habe ich mich mit der Funktion des SNARE-Proteins 
Syntaxin11 beschäftigt. Dazu wurde die Syntaxin11 Expression in humanen CTLs durch 
Transfektion einer spezifischen siRNA herunterreguliert. Anschließend wurde mit 
biochemischen, durchflusszytometrischen und mikroskopischen Techniken untersucht, 
welchen Einfluss die Entfernung von Syntaxin11 auf die Funktion der CTLs hatte.  
In einem durchflusszytometrischen Degranulationsassay konnte ich zeigen, dass die 
Exozytose von Lysosomen, wovon LG eine Subpopulation sind, stark reduziert war. 
Außerdem konnte mit TIRFM nachgewiesen werden, dass die Verweilzeit (dwell time) 
von LG an der Immunologischen Synapse (IS) verlängert und die Zahl der 
Fusionsereignisse reduziert ist. Passend zu diesen Beobachtungen zeigte ein 
Zytotoxizitätsassay eine starke Beeinträchtigung der siRNA behandelten CTLs in ihrer 
Fähigkeit, Zielzellen zu töten. Zusammenfassend zeigen diese Experimente, dass 
siRNA behandelte humane CTLs einen Zytotoxizitäts-Defekt besitzen und sich 
phänotypisch wie CTLs aus Patienten verhalten, die an einer erblichen 
immunologischen Erkrankung leiden, bei der das Syntaxin11 Gen mutiert ist (FHL-4).  
Um die zellbiologischen Prozesse zu identifizieren, an denen Syntaxin11 beteiligt ist 
und die zu dem beschriebenen Zytotoxizitäts-Defekt führen, wurden mikroskopische 
(Co-) lokalisationsstudien durchgeführt. Es zeigte sich, dass Syntaxin11 zusammen mit 
recycling TCR und Rab11a in sogenannten Recycling-Endosomen auftritt, aber nicht in 
den LGs selbst vorkommt. Diese Beobachtung führte zu der Hypothese, dass 
Syntaxin11 bei der Etablierung der IS möglicherweise über Recycling-Endosomen an 
die Plasmamembran transportiert wird und nach Fusion als Target-SNARE für LGs 
dient. Zur Überprüfung dieser Hypothese wurde die Etablierung der IS in lebenden 
Zellen, bei denen sowohl die LGs als auch die Recycling-Endosomen markiert waren, 
mikroskopisch beobachtet. Es konnte eindeutig die erwartete zeitliche Abfolge von 
Ereignissen gefunden werden. Nachdem die CTLs Kontakt mit ihren Zielzellen 
aufgenommen hatte, wanderten zunächst die Syntaxin11 tragenden Vesikel an die 
Membran. Erst nachfolgend trafen die LGs ein. Diese Beobachtungen wurden mit 
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TIRFM bestätigt. Auch mit dieser Technik konnte zunächst das Eintreffen der 
Syntaxin11 tragenden Vesikel an der IS gezeigt werden. Erst später trafen die LGs ein.  
Wir interpretieren dese Daten in der Weise, dass der Aufbau der IS zunächst durch den 
Antransport von Syntaxin11 und möglicherweise weiterer molekularer Komponenten 
durch Recycling-Endosomen erfolgt. Erst nachdem die molekularen Komponenten 
eingetroffen sind, werden die LGs antransportiert und können fusionieren. Syntaxin11 
ist dabei wahrscheinlich das Target-SNARE für die Fusion von LGs. Anders als in der 
verfügbaren Literatur vorgeschlagen, gehen wir nicht davon aus, das Syntaxin11 bei der 
Reifung von LGs eine Rolle spielt, da LGs nicht mit Syntaxin11 kolokalisiert sind und, 
wie in der vorliegenden Arbeit auch gezeigt, die Gesamtzahl der LGs in einer CTL und 
an der IS nicht von Syntaxin11 abhängig ist. Allein der Fusionsprozess ist Syntaxin11 
abhängig. 
 
Die vorliegende Arbeit beschreibt erstmals einen exozytotischen Weg in CTLs der 
Bausteine der IS transportiert. Dieser Weg ist unabhängig von Reifung und Transport 
der LGs selbst, ist aber eine Voraussetzung für deren Fusion. Diese Daten tragen zum 
Verständnis der cytotoxischen Funktion von CTLs bei und helfen, das 
pathophysiologische Geschehen bei FHL-4 besser zu verstehen.  
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1. INTRODUCTION 
1.1 Human cell defense systems – the immune system 
The immune system functions to protect our body from bacteria, viruses, fungi and 
parasites, collectively known as pathogens, as well as environmental pollutants. The 
immune system provides three lines of defense that are dependent upon severity of the 
infection. The first line of defense includes non-specific barriers, such as physical and 
chemical barriers. The second line of defense consists of polymorphonuclear 
(granulocytes) and mononuclear (agranulocytes) leukocytes. Granulocytes include 
neutrophils for phagocytosis, eosinophils for destruction of parasitic worms and antigen-
antibody complexes and basophils which release heparin and histamine. Furthermore, 
monocytes are later converted into macrophages in various tissues. Agranulocytes 
include B and T lymphocytes which mediate antigen-specific immune responses. 
(Abbas, 2007; Goldsby, 2000). 
1.2 Innate and adaptive immune systems 
The innate immune system provides non-specific immune responses which occur 
rapidly and do not confer the long term protection. In contrast, the adaptive immune 
system responses are both specific and long lasting. In vertebrates, this provides the 
immune system with the ability to specifically recognize and remember a pathogen, 
allowing a more rapid and robust response if the pathogen is encountered again. Hence 
the name adaptive since the body adapts after challenge. Recent advances in basic 
immunology provide more evidence for extensive interdependence and cross-talk 
between the innate and adaptive immune systems, which provides more stable and 
constant protection from foreign pathogens (Eisenbarth and Flavell, 2009; Tipping, 
2006).  
1.3 Development and differentiation of immune cell lineages  
Immune cells originate in bone marrow from CD34+ hematopoietic stem cells (HSCs) 
and differentiate based on requirements of the immune system and the availability of 
specific growth factors for differentiation. The turnover of the cells of the hematopoietic 
system in a man weighing 70 kg can be estimated to be approximately 1 trillion cells per  
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Figure 1: Differentiation of T lymphocytes from progenitor stem cell 
Differentiation of hematopoietic progenitor stem cells into all other blood cell types from common lymphoid progenitor 
cells (CLP) and common myeloid progenitor cells (CMP). CLP cells differentiate into T and B lymphocytes and CMP 
cells differentiate into erythrocytes, platelets, basophils or mast cells, eosinophils, neutrophils, monocytes and 
macrophages (Ref: figure modified from Stem cell resources, Sigma Aldrich). 
 
day, including 200 billion erythrocytes and 70 billion neutrophilic leukocytes. This 
remarkable cell renewal process is supported by a small population of bone marrow 
cells termed as hematopoietic stem cells (Ogawa, 1993). The process of hematopoiesis 
is the production of blood cells from HSCs in the presence of growth factors and 
cytokines like G-CSF, GM-CSF, M-CSF, IL-1, 6, 7, 8, 10, 11, SCF, LIF, MP 1α, β, TGF- 
β and TNF- α, etc., as depicted in a hierarchical fashion (Figure 1). HSCs first give rise 
to the two progenitors, the common myeloid progenitor (CMP) and the common 
lymphoid progenitor (CLP). CMPs produce erythrocytes, thrombocytes, neutrophils, 
monocyte/macrophages, eosinophil, basophils and mast cells, whereas CLPs generate 
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B cells, NK cells and T cells (CD4+ and CD8+). A flow chart for differentiation of the HSC 
into different lineages is depicted in figure 1 (Orkin, 2000). 
 
1.4 Lymphocytes 
Lymphocytes consist mainly of T cells, B cells and NK-cells. T lymphocytes and B 
lymphocytes are the major cellular components of the adaptive immune system where T 
lymphocytes function in cell mediated immunity and B lymphocytes contribute to 
humoral immunity. The interaction between T lymphocytes and antigen presenting cells 
(APCs) is the basis of the adaptive immune system (Goldsby, 2000). Unlike T cells and 
B cells, NK cells are critical to the innate immune system and consist of large, granular 
lymphocytes that do not express the same set of surface markers as B or T cells. Naïve 
T and B lymphocytes are small (Bromley and Dustin, 2002). But once they are exposed 
to an antigen, they proliferate, producing blasts called lymphoblasts. These cells have a 
higher cytoplasm to nucleus ratio and more organellar complexity than naïve 
lymphocytes. Lymphoblasts ultimately proliferate and become effector cells or memory 
cells. Effector cells consist of two types of cells, T helper cells (CD4+) and cytotoxic T 
lymphocytes (CTLs/CD8+). 
 
1.4.1 Early activation  
CD8+ cells mature and migrate from the thymus to the lymph nodes, where they 
recognize specific antigen presenting cells (APCs) via T cell receptors (TCRs) and 
major histocompatibility complexes (MHC) that are found on the surface of APCs such 
as dendritic cells (DCs), macrophages and B cells (Gay, 1987). T cell and DC 
interactions have three different phases. The first step of T cell activation occurs in the 
thymus, where T cells and DCs engage in an initial recognition and conjugation lasting 
for 8 hours (h). This interaction results in several short encounters between migratory T 
cells and DCs, which are independent of antigen interactions and contribute to the 
maintenance of the T cell repertoire in the absence of T cell activation (Tanchot, 1995). 
Specific recognition of DCs by naïve T cells via the MHC molecules results in a mature 
synapse that lasts for 30 min (Huppa and Davis, 2003) and leads to the expression of 
the early activation markers CD44 and CD69. The second phase of naïve T cell 
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activation lasts ~ 24 h after T cell migration and is associated with upregulation of the 
surface marker for the IL-2 receptor (CD25), considered as an activation marker for 
lymphocytes. Prolonged stable contact between lymphocytes and DCs in the thymus 
elicits an increase in CD8 clusters on the surface of lymphocytes in contact with the 
DCs, indicating the final phase of T cell activation, the establishment of a mature 
synapse through MHC:TCR mediated signaling (Hurez et al., 2003; Bousso, 2004). 
 
1.4.2 Naïve to activated cytotoxic T lymphocytes (CTLs) 
The naïve T cell pool is not stable in number, diversity or function in the absence of a 
strong stimulus, in contrast to the maintenance of the T cell repertoire in the absence of 
activation. Mature naïve T cells can survive for many days without proliferation, after 
they migrate from thymus. In order to recognize a variety of foreign antigens, naïve T 
cells maintain a large number of clones with unique receptors within the thymus. Hence, 
not only the numbers but also the diversity and functional competence of the naïve T 
cell population must be maintained. The signals for naïve T cell homeostasis involve T 
cell receptor (TCR) engagement using self-peptide-MHC complexes and interleukin-7 
receptor (IL-7R) stimulation by IL-7 (Takada and Jameson, 2009). During the initial and 
late activation of naïve T cells, they undergo drastic rearrangements of their molecular 
and cellular components in order to reach an activated state. CD3 molecules play an 
important role in this process by initiating calcium signaling, which ultimately results in 
the activation of a complex signaling pathway allowing naïve T cells to become CTLs 
(killing competent). TCR recognition, followed by downstream calcium signaling, which 
includes key components like Src kinases, ITAMs, ZAP-70, PLCγ, IP3 and DAG in 
association with STIM/ORAI calcium channels, lead to the T cell activation (Garvin et 
al., 2009; Kummerow et al., 2009). Activated T cells are now capable of conjugating 
with specific target cells through TCR-CD3 molecules and establishing a firm contact 
zone called the Immunological synapse (IS). During this time, the cell is actively 
producing the components required for the killing process. There are two independent 
pathways which lead to target cell death; the first one is calcium dependent, in which 
cytotoxic granules are required for lytic function (Becherer et al., 2012); The second one 
is calcium independent and involves components of the FAS ligand signaling (CD95; a 
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member of the tumor-necrosis factor receptor family of death receptors) pathway and 
does not require perforin (Helgason et al., 1992; Barry and Bleackley, 2002).  
 
1.5 Cytotoxic T lymphocytes  
Naïve CD8+ T cells acquire killing competence after activation by producing the lytic 
substances required for killing. Three important aspects of the conversion from naïve to 
activated CTLs include; IL-2 expression or IL-2 receptor expression, proliferation and 
the gain of cytotoxic ability. In the case of CD4+ cells, only Th1 (T helper cell subset 1) 
cells are cytotoxic (Hahn et al., 1995). After activation, naïve CD4+ T cells undergo 
vigorous clonal expansion and differentiation. This massive proliferative response, 
accompanied by clonal selection for the immune function of CD4+ T cells in the 
periphery, allows CD4+ cells to differentiate into mature TH1, TH2 or TH17 cells (Reiner, 
2009). These TH-subsets help other immune cells to activate, providing them direction 
by engaging in B cell antibody class switching, the activation and growth of CTLs and 
the activation of macrophages to fight against bacterial infection. 
After antigen-specific recognition, the integrin receptor LFA-1 on the CTL membrane 
binds to ICAMs on the target cell membrane, resulting in the formation of a conjugate. 
Antigen-mediated CTL activation converts LFA-1 from a low-avidity state to a high-
avidity state. Because of this phenomenon, CTLs adhere to and form conjugates only 
with specific target cells that display the antigenic MHC complex. CTLs then engage in 
TCR/CD3 mediated recognition of target cells followed by sequential induction of 
calcium signaling that leads to polarization of CTL towards its target cell. Initially, CTLs 
crawl and move in search of an APC with the help of flagella like structures called 
uropods (Fais and Malorni, 2003). These uropods enable CTLs to move and sense the 
presence of MHC class I molecules with an antigenic peptide on the surface of APCs. 
Stable IS formation depends on the strength of TCR accumulation. This TCR signaling 
strength also influences target cell death, as TCR signaling controls centrosome 
polarization to the cSMAC followed by delivery of LGs (Jenkins et al., 2009; Krammer, 
2000; Peter and Krammert, 1998). TCR dependent stable IS formation results in killing 
of the target cell through three pathways. Killing occurs by lytic granule release (O'Keefe 
and Gajewski, 2005), cytokine release (Andersen et al., 2006) and Fas ligand mediated 
apoptosis (Nagata, 1996). Nevertheless, one major disadvantage of active CTL function 
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is an autoimmune disease (Section 1.8) in which CTLs recognize the organisms own 
(self)-cells as a target cell and destroy these cells or tissues, ultimately resulting in 
death. Hence, the alternate description of CTL function is that ‘all roads lead to death’ 
(Barry and Bleackley, 2002). 
 
1.6 Immunological synapse (IS) 
As a result of CTL recognition of target cells harboring a cognate MHC-bound peptide 
antigen, a dynamic reorganization of membrane and cytosolic molecules occurs at the 
CTL-APC contact zone. This interaction results in the formation of a stable and highly 
organized IS, where the CTL prepares a zone of close contact with the target cell for 
release of its cytotoxic components to kill the target cell. The term ‘synapse’, which 
means junction, was initially used for neuronal connections. The term ‘immune synapse’ 
was first proposed by Norcross and Paul to describe the CTL-APC conjugation. CTL 
and NK cell synapses have a high degree of similarity. However, NK cells actively 
secrete LGs without having APC contact, unlike CTLs which synthesize LGs only after 
APC interaction (Huppa and Davis, 2003; Finetti et al., 2009). IS formation is a dynamic 
process that includes the rearrangement and polarization of components within CTL 
towards the contact zone with the target cell. Signaling molecules of IS formation 
include the TCR/CD3 complexes (cSMAC), which induce downstream calcium signaling 
and involve PKC-θ. Activation of this pathway is rapidly followed by migration of cell 
adhesion molecules such as ICAMs, LFA1 (pSMAC) and the cytoskeleton linker talin, 
along with CD43 and CD45 (dSMAC) as depicted in figure 2 (Delon et al., 2001). The 
process of mature synapse formation is divided into three major steps which include 
several smaller steps (Orange, 2008). Briefly, the initial stage is the recognition of 
membrane bound receptors that lead to cell to cell interaction and anchor the CTL to its 
target cell. This step depends on cell adhesion molecules which establish a firm contact 
zone that causes the CTL to stop migrating, allowing it to form an increasingly stable 
contact with the target cell. The next step is the effector stage that occurs after a stable 
IS has formed, creating the interface between CTLs and target cells to which lytic 
granules are recruited.  
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Figure 2: Cell to cell contact zone for lytic granule release: The immunological synapse 
(a) TCR/CD3 complexes and the MHC-I complex mediate conjugation between effector cells (T cell) and target cells 
(APC) leading to formation of a mature synapse (the IS) for release of lytic components into the target cell cleft. (b) 
Organization of a mature synapse showing the central, peripheral and distal rings of its components (Huppa and 
Davis, 2003). 
 
LG maturation, polarization and fusion processes are tightly controlled by the MTOC 
(microtubule organizing center) and SNARE proteins. The MTOC directed movement of 
lytic granules is directly dependent on the motor function of dynein and kinesin-1. The 
mature synapse required for LG arrival and fusion includes several complexes that form 
an association at the CTL:APC interface. Initial recognition and early events mainly 
include CD8, along with TCR/CD3:MHC complex, CD44/45 and the LFA1:ICAM1 
complexes that strengthen adhesion. Additionally, CD28 binds to CD48/59 on APCs 
involved in stimulating IL-2 expression and production. CD2, in association with CD48, 
supports adhesion as depicted in figure 2 (Mentlik et al., 2010; Stow et al., 2006). In the 
final phase after the maturation of the synapse, recycling endosomes deliver key 
components of vesicle fusion, such as priming factors, proteins that mediate docking 
and various components of the fusion machinery soluble N-ethyl-maleimide-sensitive 
attachment protein receptor (SNAREs), required for LG exocytosis (de Saint Basile et 
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al., 2010; Stow et al., 2006). After killing, the CTLA4 (CD-152):CD86 complex functions 
to aid the dissociation of the CTL:target cell complex. 
 
1.7 Soluble N-ethyl-maleimide-sensitive attachment protein receptors (SNAREs) 
SNARE proteins are the mediators of intracellular membrane fusion events and play a 
crucial role in exocytosis by allowing release of vesicular contents. Generally, trafficking 
is an exchange of materials between two intracellular compartments or the release of 
contents from a vesicle membrane to a target membrane (Chen and Scheller, 2001; 
Jahn et al., 2003). The mechanism of SNAREs and SNARE associated proteins are 
well studied in neuronal synapses (Fasshauer et al., 1998a), neuroendocrine cells 
(Kesavan et al., 2007), cytotoxic T lymphocytes (Stow et al., 2006), pancreatic beta 
cells (Jewell et al., 2010), etc. SNAREs have a characteristic domain structure called 
the SNARE motif or the coiled-coil domain, containing an evolutionarily conserved 
stretch of 60–70 amino acids that are arranged in heptad repeats. Most of the SNARE 
proteins have single transmembrane domains at their C-terminus that connects to the 
SNARE motif by a short linker (Kesavan et al., 2007). These proteins also have N-
terminal domains that vary between the subgroups of SNAREs. However, the current 
classifications of SNAREs are based on either their localization or composition. SNARE 
proteins are classified based on their localization to vesicular or target membrane, v-
SNAREs for SNAREs associated with vesicles and t-SNAREs for those associated with 
target membranes (Sollner et al., 1993). However, these classifications were confusing 
when it comes to the homotypic fusion of vacuoles. Thus, an alternative classification 
has evolved which is based on the residue at the center of the zero ionic layers in the 
coiled-coil domain. R-SNAREs contain an arginine and Q-SNAREs contain a glutamine 
at this position. Q-SNAREs are farther divided into Qa, Qb and Qc SNAREs and a 
functional SNARE complex consists of a four helix from each Qa, Qb, Qc and R-SNARE 
(Fasshauer et al., 1998b). Together these four helices constitute a functionally stable 
SNARE complex that lowers the activation threshold for membrane fusion and induces 
fusion between vesicular and target membranes (Bock et al., 2001). The crystal 
structure of SNARE complexes revealed that a SNARE complex consists of four helical 
bundles and zero ionic layers which consists of leucine, isoleucine and valine residues 
in heptad repeats (Sutton et al., 1998). The glutamine residues from Syntaxins and 
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SNAPs and the arginine from VAMPs, forms a central ionic interaction layer (the zero 
layer) or hydrophobic core of the SNARE complex (Figure 3). Thus, four coiled-coil 
domains collectively create an electrostatic potential which results in membrane fusion. 
These SNARE complexes are thermally stable and can withstand temperatures up to 
90°C (Hayashi et al., 1994). Following a successful fusion event, SNARE complexes 
are disassembled by N-ethylmaleimide-sensitive fusion protein (NSF) and alpha-SNAP 
proteins (Barnard et al., 1996).            
Recent studies (Stow et al., 2006) have highlighted the importance of SNARE and 
SNARE associated proteins in membrane fusion and trafficking in almost all aspects of 
immune cells, including CTLs. A number of inherited diseases of the immune system in 
humans are associated with defective membrane fusion in immune cells. For example, 
mutations in Munc13-4 (Feldmann et al., 2003), Syntaxin11 (Bryceson et al., 2007) and 
Munc18-2 (zur Stadt et al., 2009) all result in an inheritable genetic defect called familial 
hemophagocytic lymphohistiocytosis (FHL).  
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Figure 3: SNARE proteins, regulators of membrane fusion 
A model for zippering of four SNARE helices (a), v-SNARE protein VAMP (in blue) on the vesicle along with target 
SNAREs on the plasma membrane. The Qa-SNARE Syntaxin (in red) and Qbc SNARE, SNAP-25 (in green) before 
and after formation of the four-helix bundle, including the zero ionic layer. (b) The backbone of the SNARE complex 
with Q-SNAREs and R-SNAREs are characterized by a glutamine (Q) or arginine (R) residue, respectively, in the 
central layer of the SNARE complex (Chen and Scheller, 2001). 
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1.8 Genetic disorders associated with CTL function 
There are several diseases associated with immune dysfunction which develop due to 
defective CTL function resulting in severe clinical manifestations. Wiskott-Aldrich 
Syndrome (WAS) is an immunodeficiency disease that originates from mutations in the 
gene encoding WASP (Wiskott-Aldrich syndrome protein), a key actin regulator of 
immune cells (Li et al., 2003). WAS deficient CTL cell lines show normal numbers of 
LGs and normal exocytosis. However, WAS CTLs also show clear defects in the 
polarization of LGs to the IS. Hermansky-Pudlak syndrome (HPS mutations in the 
paladin protein) is a genetically heterogeneous disorder characterized by 
oculocutaneous albinism, prolonged bleeding and pulmonary fibrosis due to abnormal 
vesicle trafficking of lysosomes and related organelles in melanosomes and of dense 
granules in platelets (Li et al., 2003). Griscelli syndrome is an autosomal recessive 
disorder resulting in albinism because of pigmentation loss in skin and hair, primarily 
due to vesicular trafficking defects in melanocytes (Schmid et al., 2008). Interestingly, 
mutations within the Rab27a gene are directly associated with Griscelli syndrome. 
Moreover, Rab27a deficient CTLs exhibit a hemophagocytic syndrome caused by 
defective CTL cytotoxicity and Rab27a knockout mice (ashen mice) display defects in 
the granule mediated killing pathway (Menasche et al., 2000).  
Chediak–Higashi syndrome (CHS) is characterized by mutations in the lysosomal 
trafficking regulator protein (LYST) leading to a rare autosomal recessive defect 
associated with the CTL granule-mediated killing pathway. CHS is characterized in its 
classical form by albinism, a bleeding diathesis; infections mediated by defective 
neutrophil and natural killer cell function and an eventual progression to 
hemophagocytosis. CHS typically results in death due to infection (Baetz et al., 1995). 
Lastly, mutations in a transcript variant of VAMP8 gene which is involved in platelet 
degranulation is associated with early-onset myocardial infarction (Shiffman et al., 
2006). In summary, SNAREs and SNARE associated proteins along with LYST and 
WASP proteins are required for normal LG fusion and defects in this pathway lead to a 
profound disturbances in lymphocyte homeostasis in humans. 
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1.8.1 Familial hemophagocytic lymphohistiocytosis  
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disorder 
featuring hyperactivated immune cells resulting from an excessive production of 
cytokines from CTLs. This excessive cytokine production leads to over activation of a 
variety of immune cells, such as macrophages, which then infiltrate into organs, causing 
organ failure and eventually death. Early symptoms include prolonged fever, 
hepatosplenomegaly, cytopenia and hyperferritinemia. Neurologic abnormalities include 
increased intracranial pressure, neck stiffness, irritability, cranial nerve palsies, ataxia, 
coma, blindness, hemiplegia, quadriplegia, rashes and lymphadenopathy (Henter et al., 
1998; Janka, 2007). The average survival rate of children with typical FHL, if left 
untreated, is less than two months and the majority of deaths in untreated children are 
due to infection.  
A mutation within the coding region of the PRF-1 gene (Perforin: pore forming protein) 
was originally identified as the cause of FHL-2. Perforin is a key molecule in CTLs that 
functions at the IS to form pores on the target cell membrane, allowing the contents of 
LGs to enter the target cell in order to induce apoptosis. Mice lacking perforin show a 
reduced but not abolished killing activity of CTLs, even though perforin is crucial for 
effector T cell and NK cell mediated cytolysis (Lowin et al., 1994). Similarly, mutations 
within the coding region of human Munc13-4 cause FHL-3. The Munc13 protein family 
is a family of specialized proteins well studied as priming factors in neuronal synapses. 
Initially, there were only 3 recognized isoforms of Munc13s; Munc13-1, 2 and 3 (Brose 
et al., 1995). Deletion of these proteins leads to a complete loss of synaptic 
transmission. Munc13-2 is reported to be expressed in hippocampal synapses. A fourth 
member of the Munc13 family, Munc13-4, has recently generated interest due to its 
function in human CTLs. Mutations in the coding region of Munc13-4 are directly 
associated with FHL-3, a form of FHL which is fatal. Human Munc13-4 is localized to 
cytotoxic granules at the IS and its loss in humans (FHL-3 patients) leads to defective 
priming but not docking of secretory vesicles at the IS (Feldmann et al., 2003). Recently 
two more genes have been reported to have direct association with FHL, i.e. FHL-4 and 
FHL-5, which code the proteins Syntaxin11 and Munc18-2 respectively. However, the 
molecular mechanism behind these functional consequences is not clear.  
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1.9 Syntaxin11  
Syntaxins have a carboxy-terminal transmembrane domain for membrane anchoring 
and a coiled-coil region for SNARE complex formation. 15 members of the human 
Syntaxin family members have been reported. Syntaxin1-4 are primarily present on the 
plasma membrane (Bennett et al., 1993); Syntaxin3 is involved in the regulation of 
apical membrane transport in epithelial cells (Riento et al., 1998); Syntaxin4 is localized 
to dendritic spines (Kennedy et al., 2010); Syntaxin5 and Syntaxin16 are on the Golgi 
apparatus (Bennett et al., 1993; Tang et al., 1998b); Syntaxin6, 10, 12 and 16 are 
distributed on the trans-Golgi apparatus (Wang et al., 2005); Syntaxin7 is localized to 
early endosomes (Pattu et al., 2011; Wong et al., 1998); Syntaxin17, 18 are present on 
ER-Golgi intermediate compartments (Hatsuzawa et al., 2000; Muppirala et al., 2011) 
and Syntaxin8 is localized to both early and late endosomes (Prekeris et al., 1999). 
Syntaxin11 has an N-terminal Habc domain, followed by linker region connecting to 
coiled-coil domain. Unlike other Syntaxins, Syntaxin11 lacks a transmembrane domain 
(TMD) (Tang et al., 1998a), which is a characteristic feature of the Syntaxin family 
members. Not all SNARE proteins harbor TMD and some SNAREs such as neuronal 
SNAP-25 (Ravichandran et al., 1996) have a palmitoylation region allowing fatty acids 
such as palmitic acid to interact with cysteine residues allowing membrane association. 
The C-terminal carboxyl tail of Syntaxin11 has five cysteine residues enabling it to 
interact with plasma membrane via palmitoylation.  
A wide variety of mutations in Syntaxin11 have been reported in patients suffering from 
FHL-4, which include complete loss of protein (Marsh et al., 2010), point mutations 
(Rudd et al., 2006), exon deletions (zur Stadt et al., 2005) and frame shift mutations 
(Macartney et al., 2011). Stx11 gene mutations are reported to be independent of 
associated FHL subtypes i.e., FHL-2 and FHL-3.  
It has been proposed that Syntaxin11 is the target SNARE for lytic granules (de Saint 
Basile et al., 2010; Hong, 2005). However several other predictions which are mainly 
based on the localization have been reported in a variety of cell types. Syntaxin11 is 
expressed in CTLs and NK cells and is localized to membrane-associated structures in 
the cytoplasm and is required for cytotoxic function (Arneson et al., 2007; Bryceson et 
al., 2007). In monocytes or macrophages, Syntaxin11 is required for platelet secretion 
(Ye et al., 2012). It is localized to the cation-dependent mannose-6-phosphate receptor 
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(M6PR) containing compartment and Rab27a positive vesicles and likely mediating the 
fusion of these vesicles with cytotoxic granules (Dabrazhynetskaya et al., 2012). 
Syntaxin11 interacts with Vti1b and mediates fusion between late endosomes and 
lysosomes in macrophages (Offenhauser et al., 2011). Furthermore, it is localized to the 
TGN (Trans-Golgi network) and late endosomes in HeLa cells (Valdez et al., 1999), 
TGN and cis-Golgi complex (Prekeris et al., 2000), distinct cytoplasmic granules in 
neutrophils (Xie et al., 2009), growth hormone (GH) containing granules in GH 
producing cell line MtT/S cells (Kawashima et al., 2010), post-Golgi complex in normal 
rat kidney cells (NRK cells) (Advani et al., 1998) and the plasma membrane in 
macrophages and many other cell types (Zhang et al., 2008).  
Cognate interacting partners for Syntaxin11 were also suggested based on in-vivo, in-
vitro studies and based on its localization. In HeLa cells and B lymphocytes, it is 
associated with VAMP and SNAP-25 on late endosomes (Valdez et al., 1999). Recently, 
two independent groups have identified mutations within gene encoding for Munc18-2, 
proposed to be a close interacting partner for Syntaxin11, as another cause of FHL, 
FHL-5. Moreover, interaction studies with mutant forms of Munc18-2, result in reduced 
steady state levels of endogenous Syntaxin11 protein, causing a severe defect in 
secretion of LGs (Cote et al., 2009; Lopez and Voskoboinik, 2013; zur Stadt et al., 
2009).  
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1.10 Aim of the work 
Cellular trafficking is the fundamental process underlying all the subcellular and 
intercellular exchange of material. For instance, proteins produced by de-novo synthesis 
leave the ER for further processing in the Golgi apparatus. Many of these proteins will 
be inserted into lipid membrane bound organelles which are then transported actively to 
their target regions. Cell membrane targeted protein will reach the membrane via fusion 
of their transport organelle with the cell membrane. This final fusion step is mediated by 
SNARE proteins, as are all membrane fusion processes in cells. Cytotoxic T 
lymphocytes are not an exception and SNARE proteins have been extensively studied 
as major regulators of CTL function. The killing function of CTL involves several 
processes that include intercellular interactions, one of which is the formation of the 
functional IS. The release of lytic granules via exocytosis to specific target cells also 
requires SNARE complex driven fusion. Mutations in many of the candidate genes or 
proteins, for example PRF1 (FHL-2), Munc13-4 (FHL-3), Stx11 (FHL-4), Stxbp2 (FHL- 
5), Rab27a (GS) etc., involved in this highly orchestrated pathway lead to severe 
consequences including death. 
The specific contributions of modulatory proteins such as Munc13-4 and Rab27a to lytic 
granule fusion have been studied and are well understood. However, the contributions 
of some of the other players, such as Syntaxin11 and Munc18-2, need to be elucidated. 
The complete cataloging of the cognate SNARE partners and the key SNARE 
modulatory proteins required for the final fusion of lytic granules is required to 
understand the underlying molecular mechanism behind the CTL mediated target cell 
killing process.  
In this study, our aim is to understand the importance of SNARE proteins for the final 
fusion of lytic granules at the IS. Syntaxin11, a Qa-SNARE is implicated in the release 
of lytic granules. However, its precise role has not been characterized in FHL-4 patients 
in whom Syntaxin11 function is lacking. CTLs and NK cells show a severe defect in 
LAMP1a positive vesicle degranulation, an indirect measure of LG exocytosis. We aim 
to provide a detailed functional analysis of Syntaxin11 in human CTL. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Reagents 
Agarose Roth 
Bovine serum albumin (BSA) Sigma 
Chloroform                                                Roth 
Diethylpyrocarbonate (DEPC)                                 Sigma 
Dithiothreitol (DTT)                                          Sigma 
ECL reagent                                              GE Healthcare 
EDTA (Ethylene diamine tetra-acetate)                           Sigma 
Ethanol                                                  Roth 
Ethidium Bromide                                           Life technologies 
Fetal Calf Serum (FCS)                                    Life technologies 
Formaldehyde (16%)                                       Polysciences 
Glucose                                                   Merck 
Glycine                                                   Roth 
H2O                                                     Sigma 
Nitrocellulose membrane                                    Roth 
Phosphate Buffered Saline (PBS)                               GIBCO 
Propanol                                                 Roth 
Skimmed milk powder                                      Roth 
TritonX100                                                Roth 
Tween20 Roth 
TRIzol® reagent                                            Life technologies 
 
All other chemicals, if not specified otherwise, obtained were from Sigma. 
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2.1.2 Plasmids 
Plasmid coding for pmTFP-N1 (Teal fluorescence protein), pmTFP-C1 and pmCherry-
N1 and pmCherry-C1 were generated by replacing GFP in pEGFP-C1 and pEGFP-N1 
clones (Clontech) with mTFP (Allele Biotech) and mCherry (gift from Roger Tsien) using 
Age I and Bgl II restriction digest sites. 
Syntaxin11 was amplified using cDNA obtained from human CTLs with following 
primers: 5’-TAT AAA GCT TCC ATG AAA GAC CGG CTA GCA GAA and 5’-TAT AGG 
ATC CCT ACT TGA GGC AGG GAC AGC A to add Hind III and BamH I restriction 
sites. After digestion with Hind III and BamH I, Syntaxin11 was ligated to vectors 
containing the fluorescent tags GFP- C1, TFP-C1 and mCherry-C1 at the N terminal 
end of Syntaxin11. 
Rab11a was amplified using cDNA obtained from CTLs, using primers 5’-TAT ATG AAT 
TCT ATG GGC ACC CGC GAC GAC and 5’-TAT ATA GGA TCC TTA GAT GTT CTG 
ACA GCA CTG to add EcoR I and BamH I restriction sites at each end. After digestion 
with EcoR I and BamH I, Rab11a was ligated to vectors containing fluorescent tags 
GFP- C1 and mCherry-C1 at the N-terminal end of Rab11a. 
Granzyme B was amplified using cDNA obtained from human CTLs, using the primers: 
5’ TAT ACT CGA GCC ACC ATG CAA CCA ATC CTG CTT CTG and 5’ ATA TAT CCG 
CGG GTA GCG TTT CAT GGT TTT CTT T to add Xho I and Sac II restriction sites. 
After digestion with Xho I and Sac II, Granzyme B was ligated to vectors containing the 
fluorescent tags, TFP-N1 and mCherry-N1 at the C-terminal end of Granzyme B. CD3e 
(epsilon) was amplified by PCR from clone NM_000733 (Origene technologies) with 
forward primer 5’-TAT AAA GCT TCC ACC ATG CAG TCG GGC ACT CAC TG-3’ and 
reverse primer 5’-TAT AGG ATC CCC GAT GCG TCT CTG ATT CAG GC-3’ to remove 
the stop codon and then ligated to both TFP-N1 and mCherry-N. All constructs used in 
this study were sequenced and their specificity confirmed either with a specific antibody 
or upregulation upon transfection using quantitative real-time PCR (qRT-PCR).   
The siRNAs specific to Syntaxin11 were purchased from Qiagen. Sequences for all 
siRNAs are given below. Control siRNA: UUC UCC GAA CGU GUC ACG U, 
Syntaxin11 siRNA 1: CCA GGU UCA AGA AUU GCA A, Syntaxin11 siRNA 2: CAC 
UCA AAU UGA AGU AUC A. Syntaxin11 siRNA 6: GCA UCA AGC GCG ACA CCA A. 
For TIRFM and degranulation assay, CD8+ cells were stimulated with anti-CD3/CD28 ab 
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coated beads for 48 h and then transfected using a nucleofector kit (LONZA) with both 
control and Syntaxin11 specific siRNAs (20 µM) along with a marker of lytic granule. 
Cells were washed 12 h after transfection and replaced with fresh AIMV supplemented 
with 10% FCS medium containing no IL-2. Cells were used for experiments 36 h after 
siRNA transfection. Syntaxin11 knock down was verified using qRT-PCR and 
immunoblotting. 
 
2.1.3 Media and solutions 
2.1.3.1 Solutions for CTL preparation 
  - Ficoll 
  - Hank's Balanced Salt Solution (HBSS) 
  - Erythrocyte lysis buffer: 
155 mM NH4 Cl 
10 mM KHCO3 
0.1 mM EDTA 
pH 7.3   
  - Buffer 1: PBS (GIBCO) supplemented with 0.5% BSA 
  - Buffer 2: RPMI medium (Life technologies) with 0.1% FCS 
  - AIMV medium supplemented with 10% FCS (Life technologies) 
 
2.1.3.2 Solutions for TIRFM experiments 
 10 mM extracellular Calcium solution 
 140 mM NaCl 
 4.5 mM KCl 
 5 mM HEPES 
 2 mM MgCl2 
 10 mM CaCl2 
 pH: 7.4 and Osmolarity: 300-310 mOsm. 
    0 mM extracellular Calcium solution 
    140 mM NaCl 
    4.5 mM KCl 
    5 mM HEPES 
    2 mM MgCl2 
    pH: 7.4 and Osmolarity:  
    300-310 mOsm. 
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2.1.3.2 Solutions for ELISA 
Coating buffer:  
100 mM - Na2CO3 
100 mM - NaHCO3 
Bring the volume to 1 L with distilled water (pH 9.6). 
 
Blocking solution: 
5x Assay diluent buffer (Biolegend: 421203) diluted to 1x with PBS before use. 
 
Wash solution: 
PBS + 0.05% (v/v) Tween20 (TBST). 
 
Stop solution:  
2N H2SO4 
Substrate: 3.3’ 5.5’ Tetramethylbenzidine (TMB) (Sigma: T0440). 
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2.2 Methods 
2.2.1 Peripheral blood mononuclear cell (PBMNCs) isolation 
The starting material for the isolation of PBMNCs was leukocyte reduction chambers 
(LRCs) containing whole blood obtained from the clinic of the Department of 
Haematology and Transfusion medicine, University of Saarland. All isolation steps were 
carried out at room temperature (RT). 15-17 ml of Ficoll was added to special leukocyte 
separation tubes and the tubes were spun at 1000 g for 30 s. Shown in figure 4 is a 
picture of the cone shaped LRC containing blood from a healthy donor. The hose was 
cut at the two points marked by 1 and 2 in figure 4a using sterile scissors cleaned with 
70% ethanol. First, the lower hose was cut and made to point to the inside of the 
leukocyte separation tube as shown in figure 4. Then the top tube was cut to allow the 
flow of blood through the cone. A 20 ml syringe containing HBSS was used to rinse the 
cone into the LRC as shown in figure 4b. 
 
 
 
Figure 4: Isolation of PBMNCs 
Shown above is the cone shaped leukocyte reduction chambers used for PBMNCs isolation. See text for details. 
 
The leukocyte separation tubes were then spun at 450 g for 30 min at RT without any 
brake or special settings. The leukocyte containing ring that was obtained after 
centrifugation was removed carefully with a 5 ml pipette and transferred to a 50 ml tube 
and then filled with HBSS. This step was followed by centrifugation at 250 g for 15 min 
at RT. The red pellet obtained after centrifugation was resuspended in 1-3 ml 
erythrocyte lysis buffer (Section 2.1.3.1) for the erythrocyte lysis process. After 60-120 
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s, 50 ml of HBSS was added to the pellet to stop the lysis process and the tubes were 
spun at 200 g for 10 min. 
The white pellet obtained was devoid of erythrocytes and was resuspended in 20 ml of 
cold PBS containing 0.5 % BSA. A small amount of cells were taken to make a 1:10 
dilution in PBS. Trypan blue staining was used to assess the viability of purified 
PBMNCs before using them for isolation of naïve CD8+ T cells or for stimulation with 
Staphylococcal enterotoxin A (SEA). 
 
2.2.2 Isolation of CD8+ cells  
2.2.2.1 Positive isolation  
CD8+ T cells were positively isolated from PBMNCs using a CD8 positive cell isolation 
kit (Life technologies). PBMNCs were resuspended at a concentration of 10x106 cells/ml 
in a Ca2+ and Mg2+ free phosphate buffer (supplemented with 0.1% BSA and 2 mM 
EDTA), along with 25 µl of prewashed beads per 10x106 cells. Suspended PBMNCs 
and dynabeads were subjected to constant rotation at 4°C for 20 min in order to bind 
CD8+ cells to the beads. Using a magnet, all the beads were collected and rest of the 
unbound cells were discarded to obtain a pure population of CD8+ cells. Bead bound 
cells were resuspended in RPMI with 1% FCS in a ratio of 250x106 beads per ml of 
RPMI along with the detach beads solution provided in the kit (100 µl/ml of RPMI). Bead 
bound cells were allowed to rotate constantly for 45 min at RT and then beads were 
separated from cells by using the magnet. The supernatant contained the positively 
isolated naïve CD8+ T cells. The cells were stained with trypan blue to assess the 
viability of purified CD8+ T cells. Cells were then centrifuged at 200 g for 5 min at RT 
and the pellet was resuspended in, pre-warmed AIMV medium containing 10% FCS 
with 100 U/ml of IL-2 at a density of 1.5x106 cells/ml. 
 
2.2.2.2 Negative isolation  
Naïve CD8+ T cells were negatively isolated from PBMNCs with a CD8 negative 
isolation kit (Life technologies) as depicted in figure 5. The percentage of CD8+ T cells 
obtained by this method from PBMNCs was approximately 10-15% and the initial 
number of PBMNCs for all the isolations varied according to the number of CD8+ T cells 
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required. PBMNCs were resuspended at a concentration of 100x106 cells/ml in a Ca2+ 
and Mg2+ free phosphate buffer (supplemented with 0.1% BSA and 2 mM EDTA), as the 
starting material for the negative isolation. Heat inactivated FCS and the antibody mix 
that was provided in the kit were mixed in a 1:1 ratio and added to the PBMNCs for 
incubation at 4°C by gentle rotation for 20 min. The volume of the antibody mix was 20 
μl per the starting material of 100x106 PBMNCs. For isolating from a large volume of 
PBMNCs the volumes of all the reagents were scaled accordingly for every step of the 
isolation. The cells were then washed by adding 2 ml of the isolation buffer and 
centrifuged at 300 g for 8 min at 4°C. The pellet was resuspended in 800 μl of the 
isolation buffer and then 200 μl of the pre-washed depletion dynabeads (supplied in the 
kit) were added. For prewashing, 200 μl of the depletion dynabeads were transferred to 
a fresh tube and the same volume of isolation buffer, or at least 1 ml, was added and 
mixed. The tube was placed in a magnet for 1 min and then the supernatant was 
discarded. The beads were then resuspended in 200 μl of isolation buffer. 
Subsequently, the cells and beads were mixed and incubated for 15 min at 18-25°C by 
gentle tilting and rotation. The tube was then placed in the magnet for 2 min. The 
supernatant contained the negatively isolated naïve CD8+ T cells and was transferred to 
a new tube. The cells were stained with trypan blue to assess the viability of the purified 
CD8+ T cells. Cells were centrifuged at 200 g for 5 min at RT and the pellet was 
resuspended in pre-warmed AIMV medium (Life technologies) containing 10% FCS at a 
density of 3x106 cells/ml. 
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Figure 5: Schematic outline of the negative isolation of naïve CD8+ T cells 
The isolation of naïve CD8+ T cells from PBMNCs using dynabeads (See text for details). 
 
2.2.3 Activation of naïve to effector cells (CTLs)  
2.2.3.1 Activation using anti-CD3/CD28 antibody (ab) coated beads  
CD8+ T cells after positive/negative isolation were activated using CD3/CD28 T cell 
expander beads (Life technologies) at a 1:0.7 ratio. The appropriate volume of expander 
beads were prewashed and suspended in initial volume of buffer 1 (PBS supplemented 
with 0.1% BSA, pH 7.4). The beads were then added to the cells and plated at a 
concentration of 2x106 cells/ml for 3 days in AIMV medium with 10% FCS. 
 
Mix and incubate for 20 min at 
2-8°C 
Wash cells and add 
depletion Dynabeads 
Incubate for 15 min at 18-
25°C  
Resuspend and increase 
volume 
Place in magnet for 2 min 
Transfer supernatant to 
fresh tube 
Discard beads with 
unwanted cells 
Pure and untouched target 
cells 
Add Fetal Calf Serum and 
antibody mix to PBMNCs 
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2.2.3.2 Activation using Staphylococcal enterotoxin A (SEA-superantigen)  
Whole blood samples obtained from healthy donors were subjected to RBC lysis in 
order to obtain a pure population of lymphocytes (PBMNCs). PBMNCs were stimulated 
with 0.1 µg/ml of SEA at a density of 100x106 cells/ml in AIMV medium (Life 
technologies), supplemented with 10% FCS and 100 U/ml of recombinant human IL-2. 
After 5 days, SEA-specific CTLs were positively isolated as described above (Section 
2.2.2.1).  
 
2.2.4 Quantitative real time PCR (qRT-PCR) 
2.2.4.1 RNA isolation  
RNA was isolated from 5x106 naïve CD8+ cells from healthy donors. Briefly, whole blood 
samples were subjected to RBCs lysis, followed by negative isolation of CD8+ cells from 
PBMNCs and then cells were lysed immediately in 1 ml of trizol. The remaining cells 
from the same donor were then stimulated with anti-CD3/CD28 expander beads. After 
three days of stimulation, CD8+ cells were treated the same way as naïve CD8+ T cells 
for RNA isolation.  
RNA was then isolated according to manufacturer’s protocol provided with trizol 
Reagent. Briefly, the protocol is rescaled based on 1 ml of trizol as starting material for 
isolation. The samples were spun at 11,400 g for 10 min at 4°C. The supernatant was 
transferred to a fresh tube and then incubated at RT for 5 min. 200 µl of chloroform was 
added to 1 ml of trizol and the contents of the tubes were mixed and incubated at RT for 
2 or 3 min. The tubes were spun at 11,400 g for 10 min at 4°C. The aqueous phase was 
carefully collected and transferred to a new tube and then 500 µl of isopropanol was 
added for precipitation of RNA. Samples were incubated at RT for 10 min. The tubes 
were then spun at 11,400 g for 10 min at 4°C. The supernatant was then removed and 1 
ml 75% ethanol prepared in diethyl-pyrocarbonate (DEPC) water was added to the 
pellet. The tubes were spun at 11,400 g for 10 min at 4°C. The supernatant was 
removed and the pellet was air dried at RT. When the colour of the pellet changed from 
white to transparent, 30 µl of DEPC treated water was added to dissolve the pellet.  
 
---------- Materials and methods ---------- 
- 25 - 
 
2.2.4.2 RNA quantification 
Isolated RNA was quantified using UV absorbance for concentration and an agarose gel 
for quality. RNA was diluted to 1:100 using RNase free water and absorbance was 
calculated at 260 nm and 260/280 nm. Water was used as blank control. The 
absorbance at E260 was used for calculating concentration of RNA using the following 
formula:  
RNA concentration = 40 × E260 × 100  
Where 40 stands for OD = 1 corresponds to 40 µg per ml of RNA, E260 absorbance and 
100 is dilution factor. 
= 40 × E260 × 100 = 40 × 0.100 × 100 
= 400 µg/ml 
= 400 × 0.030 (30 µl final volume) 
= 12 µg in 30 µl 
= 0.4 µg/µl final concentration of RNA. 
 
Pure preparations of RNA will have OD260/OD280 values of 1.8 to 2.0. If this value is < 2 
or 1.8 then there is possibility of protein or phenol contamination.  
An alternate way to examine the quality/integrity of RNA is to analyze samples on an 
agarose gel. Pure RNA has a band intensity for 28 S which is two times stronger than 
18 S (Figure 6), on the other hand degraded RNA shows only smear on the gel instead 
of two clear bands.  
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Figure 6: RNA quality assessment using agarose gel electrophoresis 
Total RNA was loaded on 1% gel agarose gel for determining RNA quality. From left to right: naïve (column 1) 
followed by stimulated CTLs (column 2 and 3). Similarly, naïve (column 4) followed by 1-7 days stimulated CTLs.  
 
2.2.4.3 cDNA synthesis 
Using reverse transcription, cDNA (Complementary DNA) was synthesized from 1 µg 
RNA at 42°C for 1 h using SuperScript™ II reverse transcriptase (Life technologies) in 
20 µl reaction mix. Initially, total RNA along with random hexamers and dNTPs were 
boiled at 65°C for 5 min to linearize the RNA secondary structure followed by addition of 
5x first strand synthesis buffer, 0.1 M DTT, RNaseOUT (RNase inhibitor) and 
SuperScript™ II reverse transcriptase followed by incubation at 42°C for 1 h.  
 
2.2.4.4 PCR 
The mRNA expression level of Syntaxin11 (GenBank accession number NM_003764.3) 
and the housekeeping gene ubiquitin C (UBC) were analyzed using quantitative real-
time PCR assay with the following forward and reverse primers designed using NCBI 
primer blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/): Syntaxin11 (Forward 
primer) 5’-ACT CTC GCT CCC AGT CCA GGC AA and (Reverse primer) 5’- ATG TCC 
TCG TGG GGC GAG TCA A, UBC (GenBank accession number: NM_021009.5) 
(Forward primer) 5’- ATT TGG GTC GCG GTT CTT G and (Reverse primer) 5’- TGC 
CTT GAC ATT CTC GAT GGT.  
PCR reactions were carried out in 96-well plates in 25 µl reaction volume with the 
QuantiTect SYBR green PCR master mix (QIAGEN). The reaction conditions are as 
follows: 15 min of heat activation of HotStart Taq DNA Polymerase enzyme at 95°C, 
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followed by 35 cycles of denaturation (15 s at 95°C), annealing (15 s at 60°C) and 
amplification (30 s at 72°C). At the end of the PCR reaction, a melting curve analysis 
was carried out in order to examine the specificity of the primers to their transcripts. 
Reactions were performed in duplicates for 3 independent experiments using the 
MaxPro-Mx300P Real Time PCR System (Stratagene).  
 
2.2.4.5 Data analysis 
Raw data obtained from PCR reactions were analyzed using MaxPro 3000P software 
(Stratagene). The Threshold Cycle (Ct) value for the gene of interest was normalized to 
the Ct value obtained for the housekeeping gene. The relative level of transcripts 
obtained for naïve cells was normalized to one in order to analyze the fold change in 
activated cells. 
 
2.2.5 Syntaxin11 antibody 
2.2.5.1 Selection of epitopes  
Antigenic regions or epitopes for Syntaxin11 antibody within the Syntaxin11 full length 
protein were selected using online tool ‘predicted antigenic peptides’ from 
‘universidad complutense de madrid’ (http://imed.med.ucm.es/Tools/antigenic.pl). The 
epitope regions selected were aligned with all other Syntaxin isoforms from Syntaxin1 to 
Syntaxin15 to ensure the epitope selected for Syntaxin11 was unique and did not 
overlap with any other Syntaxin family members to avoid cross reactivity. Selected 
epitopes showed 100% overlap with murine Syntaxin11, hence the antibody could be 
used in murine assays. Two epitopes were chosen that fulfill all of the above defined 
criteria, one epitope within the N-terminal end and the other close to the C-terminal end 
of Syntaxin11. 
 
2.2.5.2 Immunization 
Rabbits were immunized with a short fragment of a synthetic peptide corresponding to 
the N-terminal (amino acid 30 to 46; EDIVFETDHILESLYR-C) and C-terminal (amino 
acid 30 to 46; AKAQVRKAVQY-C) region of Syntaxin11. Synthetic peptides were 
coupled to maleimide-activated keyhole limpet hemocyanin using a carboxy-terminal 
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cysteine. The keyhole limpet hemocyanin-peptide complex was emulsified in complete 
Freund’s adjuvant immediately before injection into rabbits. Booster doses were given 
every alternate week using the same antigen emulsified in incomplete Freund’s 
adjuvant. The rabbits were bled 1 week after each immunization and bleeds were 
screened by ELISA for the highest antibody titer using the epitope peptide.  
 
2.2.5.3 Testing antibody titers using the ELISA 
ELISAs were performed to measure the antibody titer across bleeds allowing the 
selection of a high titer bleed for antibody purification. The initial aim of the experiment 
was to find out the optimal concentration of peptide to which crude sera (antibody) can 
bind that is not too low to react with sera or too high leading to saturation. The ELISA 
includes ten steps listed as follows: 
Coating peptide: The desired amount of peptide (from 1 pg to 100 µg) was dissolved in 
100 µl of coating buffer and used to coat a flat bottomed 96 well plate by incubation 
overnight at 4°C. Unbound peptides were washed using 220 µl/well of wash buffer (PBS 
+ 0.05% Tween20).  
Blocking: Peptide coated 96 well plates were blocked using 200 µl/well of 1x assay 
diluent buffer.  
Primary antibody incubation (crude sera): Different dilutions (1:500/1000/2500) of crude 
sera were prepared in 1x assay diluent buffer and added to a 96 well plate followed by 
incubation for 1 h at RT. After 1 h incubation well was washed 5 times with wash buffer 
and incubated with secondary antibody.  
Secondary antibody incubation: Secondary antibody (horse radish peroxidase donkey 
anti-rabbit from Amersham) was diluted to 1:50,000 in 1x assay diluent buffer then 
added to plates and incubated for 45 min at RT. Plates were washed 5 times with wash 
buffer and 100 µl of substrate solution was added to each well and plates incubated for 
15 min at RT in dark. The reaction was stopped immediately by adding 50 µl of stop 
solution (2 N H2SO4).  
The absorbance was measured at 465 nm with a GENios pro plate reader (TECAN).  
The rabbit sera containing highest antibody titer was selected for affinity purification.  
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2.2.5.4 Affinity purification  
Affinity purification of rabbit polyclonal anti-human Syntaxin11 antibody was carried out 
using column chromatography with sepharose beads as matrix. Purification included the 
following steps: 
Swelling of sepharose beads: Sepharose beads were activated in 100 mM HCl using 
gentle rotation at 4°C overnight. Beads are washed using a glass funnel with 100 mM 
HCl before being coupled to the epitope region peptides.  
Coupling: Sepharose beads were resuspended in 10 ml of coupling buffer containing 5 
mg of peptide, followed by overnight rotation at 4°C. Unbound peptide was washed 
away and peptide-linked beads were blocked using 10 ml of blocking buffer (0.1 M Tris 
HCl, pH 8.0) for 2 h. The blocking step was followed by a series of acidic (Sodium 
acetate 0.1 M pH 4.0 + 0.5 M NaCl) and basic (0.1 M Tris HCl+ 0.5 M NaCl) washes, 
followed by a final neutralizing wash using coupling buffer.  
Primary antibody incubation: Crude serum along with previously activated/peptide 
coupled beads were mixed in an affinity purification column and followed by overnight 
rotation at 4°C. Sera was eluted to rinse all unbound components from the column and 
washed with an excess amount of cold 10 mM Tris + 0.5 M NaCl pH 7.5.  
Elution: Matrix bound antibodies were eluted using 100 mM glycine pH 2.5, to break all 
acidic interactions between matrix bound antibodies and elute was collected in a tube 
containing 1 M Tris, pH 8.0. 
After glycine elution, the column was washed thoroughly with 10 mM Tris pH 8.8 and 
followed by a second antibody elution using 3.5 M MgCl2 to elute any remaining 
antibodies bound to the column. Flow through from all of above elution was subjected to 
a concentration step using centricon tubes (Millipore: UFC901008). 
 
2.2.5.5 Evaluation of antibody specificity 
2.2.5.5.1 Western blot 
2.2.5.5.1.1 Lysate preparation 
SEA stimulated human CTLs were washed in ice cold PBS and lysed in freshly 
prepared chilled lysis buffer (1 mM EDTA, 1 mM DTT, 50 mM Tris-Cl (pH 7.4), 1% TX-
100, 1 mM Deoxycholate, 100 mM NaCl and protease inhibitors). CTLs were 
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homogenized using a syringe five times manually in lysis buffer on ice. Lysates were 
rotated for 30 min at 4°C and insoluble material and cell debris were removed by high 
speed centrifugation. All extracts contained the protease inhibitors pepstatin A (1 µM), 
benzamidine (100 µM), leupeptin (1 µM), aprotinin (0.3 µM), phenylmethanesulfonyl 
fluoride (25 mM), trypsin inhibitor (20 µg/ml) and PefBloc SC (1 mM). 
 
2.2.5.5.1.2 Blotting 
Lysates were boiled for 10 min in 1x LDS (Lithium dodecyl sulphate) sample buffer (Life 
technologies) with 4% β-mercaptoethanol and then loaded onto a denaturing 4-12% 
Bis-tris gel. Proteins were then transferred onto nitrocellulose membrane (0.2 µm pore 
diameter). Blots were blocked using 5% skim milk powder in 1x TBS (20 mM Tris, 0.15 
M NaCl, pH 7.4) for 2 h at RT or overnight at 4°C. Blots were incubated with affinity-
purified anti-human Syntaxin11 antibody (1:500) and anti-GAPDH ab in 5% skim milk 
(1:5000). The blots were washed with TBS containing 0.05% Tween-20 (TBST) (five 
changes) followed by 1 h incubation with horseradish peroxidase donkey anti-rabbit 
secondary antibody (Amersham), diluted to 1:50,000 in SM-TBST, washed 6 times with 
TBST and developed with ECL reagent (Pierce). 
 
2.2.5.5.1.3 Western blot quantification (Densitometry) 
Quantification of Western blot was performed using ImageJ 4.16r software. TIF images 
generated out of blots were used for analysis. For measurements of pixel density, we 
multiplied the mean fluorescence value by the pixel value for each band. Normalized 
data was obtained by dividing the relative intensity over our standard as the common 
point of comparison according to standard analysis procedures. Measurements were 
then analyzed using Sigmaplot. 
 
2.2.6 Electroporation 
2.2.6.1 Plasmid electroporation 
SEA stimulated or anti-CD3/CD28 bead stimulated CTLs were used for electroporation 
of plasmid DNA (TFP-Syntaxin11, Granzyme B-mCherry and mCherry-Rab11a) was 
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carried out using nucleofection kit (LONZA). Using PBS, 5x106 cells were washed with 
PBS and resuspended in 100 µl of nucleofection solution provided with kit along with 2 
µg of plasmid DNA each for double transfection or 4 µg in case of single transfection. 
Cells were cultured without IL-2 for up to 12 h and then cells were washed and replaced 
with fresh in AIMV + 10% FCS containing 100 U/ml of human recombinant IL-2. 
 
2.2.6.2 siRNA electroporation  
Anti-CD3/CD28 bead stimulated CTLs were used for electroporation of siRNA (control 
and Syntaxin11 siRNAs) and all electroporations were carried out using a 6x106 cells 
and the human T cell nucleofection kit (LONZA). Cells were washed with PBS and 
resuspended in 100 µl of nucleofection solution provided with kit along with 20 µM 
siRNA for eletroporation. Cells were cultured for 12 h and then washed and media 
replaced with fresh AIMV + 10% FCS. 
 
2.2.7 Degranulation assay 
Degranulation assay was performed using CTLs transfected with either control or 
Syntaxin11 siRNAs. Briefly, anti-CD3/CD28 bead stimulated CTLs were transfected with 
control and Syntaxin11 specific siRNAs. 36 h after transfection, equal numbers of cells 
from control and Syntaxin11 siRNA transfected CTLs (0.5x106 cells) were plated in 
duplicates using flat bottomed 96 well plates that were previously coated with or without 
anti-CD3/CD28 ab for stimulated degranulation along with Golgi-stop monensin (BD 
Biosciences). Cells were incubated for 4 h at 37oC, then washed and resuspended in 
FACS buffer (PBS with 0.1% BSA and 5% FCS) before acquisition. Degranulation was 
measured using a PE conjugated-CD107a ab (Clone H4A3 from BD Pharmingen) which 
binds to LAMP1a containing vesicles that have fused with the plasma membrane. PE-
IgG1, κ Isotype was used as control in same experiments. Cells were acquired in FACS 
Canto II analyzer (BD Pharmingen). Data were analyzed using FlowJo software. Gates 
were set based on no antibody controls (constitutive secretion). 
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2.2.8 Cytotoxicity assay 
To analyze the killing efficiency of CTLs in control and Syntaxin11 siRNA treated cells, 
the CytoTox 96 non-radioactive cytotoxicity kit (Promega) was used. In brief, effector 
cells (SEA stimulated CTLs; E) were co-cultured with target cells (SEA pulsed Raji cells; 
T) at various effector:target cell (E:T) ratios at 37o C for 4 h in a 96 well plate in RPMI 
medium containing 2% FCS, but without phenol red. After 4 h, cells were pelleted by 
centrifugation and 50 µl of supernatant was used to measure the amount of lactate 
dehydrogenase released into the supernatant. The supernatant was incubated with a 
suitable substrate for 30 min at RT and the reaction was stopped using 1 M acetic acid. 
The absorbance was measured at 490 nm with GENios pro plate reader (TECAN). 
Cytotoxicity was calculated by subtracting LDH release from effector cells alone and 
target cells alone to effector + target cells using the following equation: % Cytotoxicity = 
(experimental – effector spontaneous – target spontaneous)/(target maximum – target 
spontaneous ) x 100. All experiments were performed in triplicate. 
 
2.2.9 Total internal reflection fluorescence microscopy (TIRFM)  
2.2.9.1 TIRFM setup 
The TIRFM setup used in this study consists of an inverted Olympus IX70 microscope 
with the following components: a solid-state laser 85 YCA emitting at 561 nm (Melles 
Griot, Carlsbad, CA, USA), a Micromax 512 BFT camera (Princeton instruments Inc., 
Trenton NJ, USA) controlled by Metamorph (Visitron, Puchheim, Germany), a TIRF 
condenser (T.I.L.L Photonics, Grafeling, Germany) and an Acousto Optical tunable filter 
(AOTF)-nC (AA optoelectronic, St Remy-les Chevreuses, France), a dual band 
FITC/Texas red filter set (# 51006, AHF Analysen technik AG, Tübingen, Germany), a 
dual-view camera splitter (Visitron, Puchheim, Germany) to separate the red and green 
channels, a Visichrome Monochromator (Visitron, Puchheim, Germany) to acquire 
images in epifluorescence. A 100x Olympus objective with a N.A of 1.45 was used for 
all TIRFM experiments. The object size which is represented in one pixel size was 130 
nm.  
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2.2.9.2 Coating of coverslips  
For artificial stimulation that mimics real antigen presenting cells, glass coverslips 
coated with anti-CD3/CD28 ab, were used. Briefly, glass coverslips (25 mm) were 
precleaned with 70% ethanol and coated with 0.1 mg/ml poly-ornithine for 30 min at RT. 
The anti-CD3 monoclonal ab (1 mg/ml) and anti-CD28 ab (1 mg/ml) antibodies that 
were used for coating were diluted in PBS to obtain concentration 30 µg/ml (CD3) and 
90 µg/ml (CD28). The maximum volume of antibody solution that was used for coating 
one coverslip was 30 µl. Coverslips were incubated with an antibody solution for 2:30 h 
in a 37°C humidified tissue culture incubator. The solution was aspirated after the 
incubation period and coverslips were then used for TIRFM.   
 
2.2.9.3 Experimental protocol for TIRFM  
CTLs used in TIRFM experiments were cotransfected with GFP-Syntaxin11 and either 
the lytic granule marker Granzyme B-mCherry or the recycling endosome marker 
mCherry-Rab11a. For all knockdown studies, CTLs were cotransfected with siRNA and 
Granzyme B-mCherry. Cells were spun down for 5 min and resuspended in 50 μl 
extracellular solution containing 0 mM Ca2+ and allowed to settle for 2 min on anti-
CD3/CD28 ab coated coverslips. The cells were then perfused with an extracellular 
solution containing 10 mM Ca2+ to optimize Ca2+ influx during secretion. Cells were 
imaged for 20 min by TIRFM at 488 nm and 561 nm. The acquisition speed was set to 
10 Hz and the exposure time was 100 ms. All experiments were carried out at RT. The 
analysis of accumulation was performed with ImageJ software. 
Syntaxin11 and LGs: For simultaneous visualization of Syntaxin11 and LGs in TIRFM, 
CTLs were cotransfected with mCherry-Syntaxin11 and Granzyme B-TFP plasmids. 
The cells were allowed to settle for 3-4 min on anti-CD3/CD28 ab coated coverslips and 
acquisition in TIRF mode was performed using 488 nm and 561 nm. The acquisition 
speed was 10 Hz and the exposure time was 100 ms. All experiments were performed 
at RT. 
Syntaxin11 and recycling endosomes (Rab11a): For simultaneous visualization of 
Syntaxin11 and recycling endosomes (Rab11a) in TIRFM, CTLs were cotransfected 
with GFP-Syntaxin11 and mCherry-Rab11a plasmids. The cells were allowed to settle 
for 3-4 min on anti-CD3/CD28 ab coated coverslips and acquisition in TIRF mode was 
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performed using 488 nm and 561 nm. The acquisition speed was 10 Hz and the 
exposure time was 100 ms. All experiments were performed at RT. 
 
2.2.10 Lytic granule fusion analysis  
Fusion analysis was carried out using ImageJ software with the plugin Time Series 
V3_2 analyzer. Fusion was analyzed as a measure of total fluorescence of all pixels 
over a selected region of interest (ROI) for single vesicle in the form of graph showing a 
sudden drop in the fluorescence of the vesicle in less than 300 ms. Each individual 
vesicle was tracked manually over time to see whether the LG (Granzyme B-mCherry) 
moves back into the cell or it fuses at the IS. Movement of the vesicle back into the cell 
can be distinguished from fusion by delayed or gradual loss of fluorescence which is 
much longer than typical fusion events.  
 
2.2.11 Dwell time analysis of lytic granules 
Dwell time is defined as the time spent by a vesicle at the plasma membrane (TIRF 
plane). Dwell time of the vesicle is calculated by tracking a single vesicle over time 
before it fuses or moves back into the cell.  
 
2.2.12 Mean fluorescence analysis 
Average number of vesicles or total fluorescence corresponding to Syntaxin11, Rab11a 
and LGs at the TIRF plane was measured using a defined threshold in ImageJ software 
(http://rsbweb.nih.gov/ij/).  
 
2.2.13 Colocalization analysis  
For TIRFM and live cell imaging data, Mander’s colocalization analysis between 
Syntaxin11, Rab11a and LGs were carried out using JACoP plugin in ImageJ. For line 
scans, ZEN2011 software (Carl Ziess) was used to draw lines and fluorescence values 
for individual pixels were exported to sigma plot.  
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2.2.14 Confocal ELYRA set up  
LSM 780 (Carl Zeiss) is regular confocal laser scanning microscope with a highly 
sophisticated light detection system composed by a 32 channel spectra GaAsP array 
and two standard alkali PMTs in positions for blue and far-red detection and a 
transmitted light detector. The confocal setup is equipped with both a 37ºC incubator 
and a 5% CO2 supply. A 40x oil objective with numerical aperture (N.A) of 1.3 was used 
for image acquisition. For acquisition, ZEN software was used with a frame size 512 x 
512 and a pinhole size of 5 (A.U). Laser light of wavelengths 488 nm, 561 nm and 647 
nm were used for excitation using a multiple band beam splitter for 488/561/633 nm. 
The laser power used was 1-2% of maximal power to avoid bleaching. Simultaneous 
confocal z-sections were taken at 1 µm intervals for whole cell analysis. In the z-
direction, a total of 6 slices were acquired with a speed of 400 ms per slice. All 6 slices 
were merged to create the maximum intensity projection from the acquired images and 
compressed to 50 frames per second using the ImageJ movie compression. 
 
2.2.15 Live cell imaging 
For live cell imaging experiments, SEA specific CTLs were cotransfected with TFP-
Syntaxin11 and with either a marker for LGs (Granzyme B-mCherry) or a marker for 
recycling endosomes (mCherry-Rab11a).  
Raji cells (target cells) were pulsed with SEA for 30 min prior to live cell imaging. CTLs 
and target cells were observed in AIMV medium at 37°C and 5% CO2 to study the 
dynamics of cells in real time. Movies were acquired using a LSM780 Carl Zeiss 
microscope. CTLs and target cells were imaged simultaneously in 3 channels with the 
following lasers; 488 nm for TFP, 561 nm for mCherry and DIC images. Images of cells 
were acquired at 1 µm intervals in the z-direction for all 3 channels simultaneously.  
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3. RESULTS 
3.1 Syntaxin11 is expressed in CTLs and up regulated upon activation  
We analyzed the expression of Syntaxin11 at the mRNA level in naïve CD8+ cells (day 
0) and after stimulation of CD8+ cells (CTLs) for three days with anti-CD3/CD28 
antibody coated activator beads, using quantitative real time PCR (qRT-PCR; figure 7). 
We found that the expression of Syntaxin11 is increased 3.19 ± 0.002 fold (n=4) upon 
stimulation for 3 days, in contrast to un-stimulated cells (naïve cells). CD8+ cells were 
also stimulated using super-antigen (SEA) and positively or negatively isolated CD8+ 
cell populations were quantified using FACS and were about 99% pure for CD8+ cells 
(Pattu et al., 2011).  
 
 
 
Figure 7: Syntaxin11 is upregulated upon activation of CD8+ cells 
Expression studies of Syntaxin11 at mRNA level using qRT-PCR in naïve CD8+ cells and three day anti-CD3/CD28 
expander bead stimulated CTLs. Expression of Syntaxin11 in naïve cells is normalized to one in order to study the 
fold change upon activation. Upon activation expression of Syntaxin11 is upregulated. Data normalized to the 
housekeeping gene ubiquitin-C (UBC). Error bars show standard error of the mean (SEM). 
  
We produced a rabbit polyclonal antibody specific for Syntaxin11 and affinity purified 
(Section 2.2.5). The epitope was a peptide corresponding to the N-terminal region of 
Syntaxin11. Western blot analysis was performed using antibody by loading varying 
amounts of CTL lysates (5 µg, 10 µg, 15 µg and 20 µg; figure 8 A). The affinity purified 
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Syntaxin11 antibody detected a single band at the expected molecular weight of 33.3 
kDa. Having verified the sensitivity of the antibody to endogenous Syntaxin11, we next 
used siRNAs directed against Syntaxin11 as a confirmation for sensitivity and 
specificity. CTLs were transfected with three different siRNAs 1, 2 and 6 (Section 
2.2.5.2) against Syntaxin11 to knockdown the expression of endogenous Syntaxin11. 
The amount of knockdown was quantified using qRT-PCR (Figure 8 C) and western blot 
(Figure 8 B). The reduction of Syntaxin11 mRNA was found to be for siRNAs 1, 2 and 6 
was reduced to 40%, 45 % and 20% of control value which is normalized to 100%, 
respectively (n=3) (Figure 8 C).  
Knockdown of Syntaxin11 was also verified using Western blot analysis (Figure 8 B) 
which detects the protein and quantified using densitometry (Figure 8D). We found a 
strong reduction in the protein levels (by 75%, 80% and 85% for siRNAs 1, 2 and 6 
respectively). The reproducibility of the knockdown for Syntaxin11 was confirmed with 
cells from 3 independent human donors. 
Based on these positive and negative controls, the Syntaxin11 antibody is specific and 
sensitive. All three siRNAs directed against Syntaxin11, were effective in reducing 
Syntaxin11 protein levels significantly. Thus the antibody and siRNAs are suitable for 
functional studies. 
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Figure 8: Affinity purified antibody is specific for Syntaxin11 in Western blot 
Antibody specificity test using Western blot (A) in which CTL lysate blotted with a polyclonal anti-Syntaxin11 antibody 
shows a single band at the predicted molecular weight of 33.3 kDa. (B) Control and Syntaxin11 siRNA transfected 
CTL lysates blotted for Syntaxin11 (upper panel) and GAPDH (lower panel) as loading control shows reduced protein 
amount in all three siRNA treated CTLs compared to control siRNA treated CTLs. (C) Quantification of Syntaxin11 
mRNA downregulation by transfection of three different siRNAs specific for Syntaxin11 using qRT-PCR shows that all 
three siRNA treated groups show reduced amount of transcript level compared to control which is normalized to 
100%. (D) Quantification of Syntaxin11 protein reduction (densitometry) from three independent experiments with a 
calibration curve derived from the right part of (D) shows that there is significant reduction in the protein level 
compared to control which is normalized to 100%. Error bars are SEM. 
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3.2 Downregulation of Syntaxin11 leads to a strong reduction in degranulation 
and a reduction in CTL mediated target cell killing 
To confirm the functional contribution of Syntaxin11 in LG exocytosis, we performed a 
FACS based LAMP1a degranulation assay (Section 2.2.6). siRNA 2 was used for all 
further functional experiments. Cells were stimulated with anti-CD3/CD28 ab for 4 h and 
labeled with LAMP1a (Lysosomal Associated Membrane Protein 1a) CD107a. Upon 
stimulation, LAMP1a is exposed to the cell surface after LAMP1a positive 
compartments (lytic granules) fuse with the plasma membrane. The surface LAMP1a 
expression can be quantified, using a LAMP1a specific antibody by FACS and serves 
as an indicator of exocytosis. Gating was performed based on the negative control (no 
antibody control). Degranulation was calculated as the percentage of cells that showed 
an increase in CD107a membrane fluorescence upon stimulation in contrast to their 
respective unstimulated counterparts. CTLs transfected with Syntaxin11 siRNA (Figure 
9 A) showed, a strong decrease in LAMP1a surface expression degranulation (Figure 9 
B), in surface expression of CD107a (LAMP1a), in contrast to control (inactive) siRNA 
(6.83% vs 28.6% respectively) indicating a defect in degranulation (76.12 ± 0.84%, n=3; 
***p < 0.001, figure 9 C). Knockdown for Syntaxin11 was confirmed for each experiment 
and was comparable to the knockdown shown in figure 8 D. Thus, Syntaxin11 is 
functional in CTLs and is required for LAMP1a degranulation. 
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Figure 9: Downregulation of Syntaxin11 leads to a strong reduction in LAMP1a degranulation 
 LAMP1a degranulation of CTLs treated with control (A) and Syntaxin11 siRNA (B). Syntaxin11 siRNA treated cells 
show reduced degranulation compared to control siRNA. Shown are representative histograms from 3 independent 
experiments. Gray area represents constitutive secretion and black line represents stimulated secretion. 
Quantification of degranulation (C) shows a reduction in degranulation by approximately 76%. Error bars are SEM. 
 
In order to study the function of Syntaxin11 in CTL mediated cytotoxicity, we performed 
a population based killing assay to test the function of CTLs that were downregulated 
with Syntaxin11 siRNA and control siRNA. We used a non-radioactive, colorimetric 
based assay which recognizes lactate dehydrogenase (LDH) released into the 
extracellular space. LDH is involved in the interconversion of pyruvate and lactate. As a 
result of CTL mediated killing, the target cell membrane becomes leaky and thus 
releases its cytoplasmic contents into the medium. The percentage of target cell lysis 
was measured as the amount of LDH that was released, at various effector:target cells 
ratios (Section 2.2.1). We found a significant reduction in the ability of Syntaxin11 
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siRNA treated cells to kill target cells in contrast to control siRNA treated cells at 
effector: target cell ratios of 20:1 (63.0 ± 2.2% vs. 30.1 ± 7.1%; **p < 0.004) and 30:1 
(100% vs. 52.5 ± 6.4%; **p < 0.003, figure 10, n=3). Our results demonstrate that 
reduction of Syntaxin11 expression in human primary CTLs by siRNA mimics the 
phenotype of FHL-4 patients and can thus be used to study the function of Syntaxin11 
with high resolution imaging.  
 
 
 
Figure 10: Downregulation of Syntaxin11 leads to reduced cytotoxicity of CTL 
CTL mediated cytotoxicity is reduced upon downregulation of Syntaxin11. SEA pulsed Raji cells and SEA-specific 
CTLs were co-cultured for 4 h at the indicated effector to target cell ratios. Experiments were performed in triplicates. 
Syntaxin11 siRNA treated CTLs show a reduced killing ability when compared to cells treated with control siRNA. 
Error bars are SEM. 
 
The defect in cytotoxicity is specifically due to the knockdown of Syntaxin11 and not 
because of other Syntaxin isoforms (Qu et al., 2011). 
Thus, we conclude that Syntaxin11 is needed for CTL effector function since 
knockdown of Syntaxin11 results in a dramatic reduction of LAMP1a degranulation and 
CTL mediated target cell killing. 
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3.3 Syntaxin11 downregulation results in a complete ablation of LG fusion at the 
IS  
Having confirmed a role for Syntaxin11 in CTL mediated cytotoxicity by LAMP1a 
degranulation and cytotoxicity assay, we aimed to identify the mechanism of Syntaxin11 
function in CTLs. For this purpose we used high resolution TIRF microscopy to study 
the behavior of individual LGs at the IS upon Sxntaxin11 downregulation. CTLs were 
transfected with Syntaxin11-siRNA or control-siRNA as described earlier. The cells 
were then transfected with Granzyme B-mCherry to mark the LGs. Previous reports 
have shown that Syntaxin11 is involved in the maturation of the LGs, meaning 
Syntaxin11 functions at a step upstream of LG fusion (Dabrazhynetskaya et al., 2012). 
Thus, one would expect to see either fewer LGs at the IS, or LGs of a different size and 
morphology accumulating at the IS. However we found no difference in the LG size or 
morphology at the IS. There was also no difference in the number of LGs at the IS. 
These results rule out an effect of Syntaxin11 upstream of LG fusion at the IS. CTLs 
that were transfected with either control siRNA or Syntaxin11 siRNA were allowed to 
settle on coverslips coated with anti-CD3/CD28 ab for 3 min in an extracellular solution 
containing 0 mM Ca2+. The cells were imaged in TIRF and then perfused with 
extracellular solution containing 10 mM Ca2+. CTLs were analyzed for the number of LG 
fusion events in TIRFM. Out of ten cells analyzed for control-siRNA treated CTLs, an 
average of 2.4 vesicle fusion events per cell were observed with a total of 24 fusion 
events (Figure 11 A; upper panel) as highlighted using red and yellow arrowheads. 
However, in Syntaxin11 siRNA treated CTLs, there was a dramatic reduction in the 
number of LG fusion events with only a total of 3 fusion events from 10 cells analyzed 
(an average of 0.3 fusion events per cell) (Figure 11 A; lower panel). Therefore in 
Syntaxin11 siRNA treated cells, there was 87.5% reduction in the number of LG fusion 
events in contrast to control siRNA treated cells (Figure 11 B). These results clearly 
implicate the direct involvement of Syntaxin11 in LG fusion. 
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Figure 11: Knockdown of endogenous Syntaxin11 results in a significant reduction in the number of LG 
fusion events 
Visualization of LGs in real time using TIRF microscopy in Syntaxin11 downregulated cells. Shown are TIRFM 
images of control siRNA transfected CTL (A- upper panel) demonstrating accumulation and decrease in number of 
LG over the time. Arrowheads indicate LG fusion. In contrast, TIRFM images of Syntaxin11 siRNA treated CTL (A- 
lower panel) show no fusion events over the entire recording time. (B) Quantification of the average fusion events of 
LG at the IS in control and Syntaxin11 siRNA transfected cells reveal a drastic reduction in the number of fusion 
events upon Syntaxin11 knockdown (n=10; **p < 0.01). Scale bars: 5 µm. Error bars are SEM. 
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3.4 Syntaxin11 knockdown reduces dwell time of LGs at the IS  
Having established a reduction in the number of LG fusion events in CTLs treated with 
Syntaxin11 siRNA, we examined LG behavior at the IS in more detail, in particular those 
LGs that do not fuse at the IS. The predicted role for Syntaxin11 is that of a t-SNARE, 
therefore we analyzed the dwell time of LGs at the IS. Dwell time can be defined as the 
amount of time spent by an LG at the IS before it fuses or moves away from the 
evanescent field. We analyzed the dwell time of LGs in CTLs treated with Syntaxin11 
siRNA and control siRNA and found that there is a significant decrease in the dwell time 
of LGs from 1.3 min (control siRNA; Figure 12 A; upper panel) to 0.4 min (Syntaxin11 
siRNA, figure 12 A; lower panel) (p < 0.001). However, when we analyzed the number 
of LGs in control and Syntaxin11 siRNA treated cells, we found that there is no 
significant difference in the number of LGs between the two groups when the 
extracellular solution contained 0 mM Ca2+. However, when the cells are perfused with 
extracellular solution containing 10 mM Ca2+, there is a significant reduction in the 
number of LGs at the IS in control siRNA treated cells in contrast to Syntaxin11 siRNA 
treated cells.  
In control siRNA treated CTLs, the number of LGs at the IS declines over time from 
about 6-7 LGs to ~1-2, over the course of the experiment. The reduction is the result of 
~2 fusion events and movement of most of the remaining granules from the TIRF field 
(Figure 13). This is expected since CTLs release very few granules at a single target 
cell. One or two granules are sufficient to kill a target cells and after release occurs, the 
CTL detaches from the target cell and moves on to the next target. On the other hand, 
in Syntaxin11 siRNA treated cells, there is a dramatic reduction in LG fusion and a 
significant increase in the number of LGs at the IS. These LGs are more mobile, 
showing active movement throughout the acquisition time. The inability of LGs to fuse at 
the IS leads to accumulation of LGs in Syntaxin11 siRNA treated cells. Thus, 
Syntaxin11 serves as the t-SNARE for the final fusion of LG at the IS. 
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Figure 12: Knockdown of endogenous Syntaxin11 in CTLs results in a reduction of LG dwell time 
Exemplary TIRFM images showing (A) the accumulation of LG over time in control siRNA treated cells (upper panel) 
and Syntaxin11 siRNA treated cells (lower panel). (B) Quantification of LG dwell time in control siRNA and 
Syntaxin11 siRNA transfected cells. Syntaxin11 siRNA treated cells show a 50% reduction in LG dwell time 
(31.87 ± 3.6 s) in comparison to cells treated with control siRNA (63.58 ± 4.8 s) (n=10; ***p < 0.001). Scale bars: 5 
µm. Error bars are SEM.  
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Figure 13: Knockdown of endogenous Syntaxin11 in CTLs results in an increased number of LGs over time 
Analysis of the average number of LGs over time in Syntaxin11 siRNA treated cells and control siRNA treated cells. 
There was no change in the number of LGs over time in Syntaxin11 siRNA treated cells, however in control siRNA 
treated cells there was a significant reduction in the number of LGs towards the end of the movie (n = 10). Error bars 
are SEM. 
 
3.5 LG and Syntaxin11 clusters associate with each other at the IS 
Our results provide evidence that Syntaxin11 serves as a t-SNARE for the fusion of LGs 
at the IS. Next, we investigated the temporal and spatial organization of Syntaxin11 
molecules at the IS and compared this to the localization of LGs. CTLs overexpressing 
full length Syntaxin11 protein fused to mCherry (mCherry-Syntaxin11, see section 
2.2.5.1) were used. To mark LGs we expressed Granzyme B-TFP by electroporation. 
The cells were then examined using TIRFM. Briefly, the transfected CTLs were allowed 
to settle on coverslips coated with anti-CD3/CD28 ab in extracellular solution containing 
0 mM Ca2+ followed by perfusion with extracellular solution containing 10 mM Ca2+. 
CTLs were then analyzed for the fluorescence intensity of Syntaxin11 (Figure 14 A; 
upper panel) and LGs (Figure 14 B; panel in the middle) in the TIRF field over time. The 
mCherry-Syntaxin11 fluorescence appears in the TIRF plane first, almost as soon as 
the CTL settles and forms an IS. The fluorescence of Syntaxin11 initially appears to be 
membrane associated as expected of a plasma membrane associated t-SNARE, 
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however later there is an aggregation of Syntaxin11 to form clusters or hotspots (Figure 
14) (Bar-On et al., 2009; Barg et al., 2010; Sieber et al., 2006). Over time several 
hotspots or clusters of Syntaxin11 appear on the plasma membrane as visualized in the 
TIRF plane. The formation of Syntaxin11 hotspots is followed by the subsequent 
accumulation of LGs in the TIRF plane (Figure 14C; lower panel) which is followed by 
fusion. CTLs transfected with control mCherry vector showed no clusters and no 
association with LGs (Figure15). Thus, LG arrival at the IS is always associated with 
Syntaxin11 hotspots and since there is a strong overlap of LG with Syntaxin11 clusters, 
we conclude that Syntaxin11 is the plasma membrane t-SNARE needed for LG fusion 
at the IS. 
 
 
 
Figure 14: Syntaxin11 forms hotspots at the IS and this is followed by LG arrival at the IS 
(A) Real time visualization of Syntaxin11 cluster formation at the IS (TIRF) (B) followed by sequential arrival of LGs 
(C) demonstrating LGs arrive at the hotspots formed by Syntaxin11 clusters at the IS. Scale bar: 5 µm.   
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Figure 15: mCherry encoding vector and lytic granules at the IS 
CTLs were transfected with vector encoding for mCherry (instead of mCherry-Syntaxin11) and the LG marker 
Granzyme B-TFP. There was no cluster formation in case of mCherry; instead the fluorescence appears to be 
cytoplasmic. Scale bar: 5 µm. 
 
Quantification of the overall fluorescence at the TIRFM for Syntaxin11 and LGs (Figure 
16) shows that fluorescence of Syntaxin11 was always more intense than that of the 
LGs, indicating that the clusters of Syntaxin11 generate a platform for landing of LGs in 
preparation for fusion at the IS. 
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Figure 16: Syntaxin11 fluorescence remains higher than LGs at the IS 
Quantification of the overall fluorescence of Syntaxin11 and LGs at the TIRF plane (n=10). The fluorescence of 
Syntaxin11 is always higher than that of LGs indicating that Syntaxin11 provides a platform for arriving LGs. Error 
bars are SEM. 
 
3.6 Syntaxin11 polarizes before the arrival of lytic granules at the IS 
Our results strongly support the evidence that Syntaxin11 is not involved in the 
maturation of LGs (Figure 11 and 12); we examined specifically early events at the IS. 
TIRF microscopy is limited to fluorescence imaging in the area of the cell that is in the 
vicinity of the plasma membrane, we sought to analyze fluorescence signals in the 
entire cell. We performed live imaging of CTLs and target cells before and after contact 
(Methods section 2.2.15) in order to visualize the dynamics of Syntaxin11 and 
Granzyme B (LGs) in the entire cell. For that purpose we used CTLs expressing TFP 
vector as a control (Figure 18) and TFP-Syntaxin11 with Granzyme B-mCherry. We 
found that Syntaxin11 positive compartments are distinct from LGs and are randomly 
distributed in CTLs when not in contact with target cells (resting phase, figure 17). As 
CTLs polarize towards the target cell (polarization phase, figure 17), there is still a clear 
distinction between Syntaxin11 and LGs, more importantly Syntaxin11 compartments 
appear to polarize first. After CTLs and target cell conjugate (Figure 17), Syntaxin11 
accumulates at the IS, followed by accumulation of LGs at the IS. The quantification of 
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colocalization between Syntaxin11 and LGs at different stages of IS formation is 
described in figure 19 (n=10) and shows a high degree of overlap between Syntaxin11 
and LGs after formation of the IS in comparison to the resting state.  
Thus, we conclude that Syntaxin11 containing vesicles polarize to the IS, delivering 
Syntaxin11 to the plasma membrane to serve as the t-SNARE for LG fusion. 
 
 
 
Figure 17: Syntaxin11 polarizes to the IS before LG accumulation 
Dynamic imaging of TFP-Syntaxin11 (second panel, green) and Granzyme B-mCherry (third panel, red) in CTLs 
before and during IS formation. The merged images in the lower panel show that Syntaxin11 accumulates first at the 
cell-cell interface after conjugation while LGs arrive later. Scale bar: 5 µm. 
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Figure 18: TFP plasmid and LGs in CTLs 
Vector encoding for TFP was transfected along with LG marker Granzyme B-mCherry. TFP appears to be 
cytoplasmic compared to vesicular TFP-Syntaxin11. Scale bar: 5 µm. 
 
 
 
 
Figure 19: Syntaxin11 overlaps with LGs at the IS 
Quantification of colocalization by Mander’s coefficient for Syntaxin11 positive compartments and LGs in resting 
polarized and conjugated CTLs. The degree of Syntaxin11 and LG overlap increases upon conjugation of CTL with 
the target cell (n=10). Error bars are SEM. 
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3.7 Rab11a containing TCR positive recycling endosomes deliver Syntaxin11 to 
the IS 
Rab GTPases are known for their association with endosomal compartments and play a 
major role in subcellular trafficking (Menager et al., 2007; Seabra and Wasmeier, 2004). 
Rab proteins such as Rab5a, Rab7a and Rab11a mark early, late and recycling 
endosomes respectively and mediate endosomal trafficking (Stenmark, 2009).  
The next question we addressed was how do the Syntaxin11 vesicles get to the IS. 
Recycling endosomes (Rab11a positive compartments) play an important role in CTLs 
and are associated with key players required for LG release since they are required for 
transport of components for building the IS (Unpublished data), including the priming 
factor Munc13-4 (Menager et al., 2007). Therefore, we compared the temporal and 
spatial organization of Syntaxin11, to that of Rab11a containing recycling endosomes at 
the IS. Rab11a was overexpressed in CTLs (Figure 20; upper panel) to specifically label 
recycling endosomes along with TFP-Syntaxin11 (Figure 20; panel in the middle) or 
TFP vector as a control (Figure 21). The CTLs were added to coverslips coated with 
anti-CD3/CD28 ab to induce the formation of an IS and images were acquired in 
TIRFM. 
We observed an early accumulation of Rab11a vesicles in the TIRF plane (at the IS) 
after the addition of CTLs to ab coated glass coverslips. Since recycling endosomes are 
involved in the early events that are necessary for the formation of an IS. We also 
observed a clear overlap between Rab11a compartments and Syntaxin11 
compartments (Figure 23 A, 24 A). However, at later time points there were more 
Rab11a vesicles than Syntaxin11 positives vesicles, as depicted in figure 22. A possible 
explanation is that, the number of Syntaxin11 (t-SNARE) molecules are highly regulated 
and this intern controls the number of LG fusion events which are required for 
subsequent killing function. 
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Figure 20: Recycling endosomes mediate the transport of Syntaxin11 to the IS 
TIRFM images of CTLs transfected with TFP-Syntaxin11 (Green) and mCherry-Rab11a (Upper panel) at the IS 
(TIRFM plane). Images are acquired initially in extracellular solution without Ca2+, after 3 min cells were perfused with 
extracellular solution containing 10 mM Ca2+. Rab11a containing recycling endosomes deliver Syntaxin11, a target 
SNARE to the plasma membrane. Scale bar: 5 µm. 
 
 
 
 
Figure 21: TFP encoding vector and recycling endosomes at the IS 
TIRFM images of the CTL transfected with vector encoding for TFP (instead of TFP-Syntaxin11) and mCherry-
Rab11a at the IS. Scale bar: 5 µm. 
 
Colocalization of Syntaxin11 and Rab11a were tested using two independent 
approaches. We used line scans followed by graphical representation as shown in 
figure 23 and also applied the Mander’s correlation as shown in figure 24. Fluorescence 
quantification of mCherry-Rab11a and TFP-Syntaxin11 at the IS over time shows that 
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(Figure 22), initial accumulation of Rab11a containing vesicles at the IS shows a strong 
overlap with Syntaxin11 fluorescence (Figure 23 A, 24 A). However, there is a 
continued steep increase in the number of Rab11a vesicles that is not associated with 
an increase in Syntaxin11; implicating Rab11a in trafficking of additional unidentified 
components to the IS. 
 
 
 
Figure 22: Quantification of recycling endosomes and Syntaxin11 vesicles/fluorescence at the IS 
Quantification of the average fluorescence of Syntaxin11 and Rab11a at the TIRF plane shows that the fluorescence 
of Rab11a constantly increases overtime, whereas Syntaxin11 fluorescence remains more or less steady implying 
that the initial recycling endosomes bring Syntaxin11 to the IS (n=10). Error bars are SEM. 
 
Syntaxin11 positive recycling endosomes are a small fraction within the recycling 
endosomes. To better define these Rab11a/Syntaxin11 positive compartments, we 
compared the colocalization of Rab11a to Syntaxin11 and then the colocaliaztion of 
Syntaxin11 to Rab11a, using the Mander’s colocalization coefficient. We observed 
complete overlap of Syntaxin11 to Rab11a; Mander’s colocalization coefficient = 0.8 ± 
0.006 (n=26) and partial overlap of the Rab11a to that of Syntaxin11; Mander’s 
colocalization coefficient = 0.2 ± 0.006 (n=26) as shown in figure 24 A. 
We then searched for a subpopulation of recycling endosomes which might be essential 
for an IS formation. TCR/CD3 complexes play a crucial role in the initial recognition of 
MHC peptide on antigen presenting cells (Section 1.8). TCR/CD3 complex trafficking 
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occurs in three different ways. TCR/CD3 complexes are constantly recycled between 
the Golgi apparatus and cell membrane as a part of constitutive process to keep a CTL 
in an active state for target cell recognition. Upon recognition, the membrane associated 
TCR/CD3 complexes are transported to contact zone (IS) to stabilize the IS. Most 
TCR/CD3 aggregates via lateral diffusion to the IS. TCR/CD3 complexes are also 
delivered to the IS actively along microtubules. Polarization of the microtubule 
organizing center (MTOC) depends on TCR signaling by microtubule motor proteins in a 
dynein dependent manner. Hence MTOC and TCR trafficking is an interdependent 
process (Billadeau et al., 2007). Another way to deliver the TCR/CD3 is via Rab11a 
positive recycling endosomes (Cemerski and Shaw, 2006). Membrane associated 
TCR/CD3 complexes are constitutively endocytosed generating recycling endosomes 
and this process depends on the di-leucine-based (diL) receptor-sorting motif in the 
TCR subunit CD3γ (Geisler, 2004).  
To define the Syntaxin11-positive vesicle subpopulation among the recycling 
endosomes, we transfected CTLs with CD3e-TFP along with Syntaxin11. There is a 
striking colocalization between Syntaxin11 and TCR/CD3 recycling compartments 
yielding a colocalization coefficient of 0.69, n = 15 (Figure 23 C, 24 C). Based on this 
result, we examined TCR and Rab11a association. To do so, we overexpressed CTLs 
with CD3e and Rab11a and carried out TIRF analysis on these cells. Overlap between 
TCR/CDe and Rab11a endosomes is comparable to that of Syntaxin11 and Rab11a 
(Mander’s colocalization coefficient is 0.72 (n=8) (Figure 23 B, 24 B).  
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Figure 23: Recycling endosomes mediate the transport of TCR positive Syntaxin11 vesicles to the IS 
TIRF images of CTLs transfected with mCherry-Rab11a along with TFP-Syntaxin11 (A) and CD3e-TFP (B) and CTLs 
co-transfected with mCherry-Syntaxin11 and CD3-TFP (C). Line scans along the stippled line on the merged images 
give rise to the fluorescence profiles (colocalization) of Syntaxin11 to Rab11a, CD3 to Rab11a and Syntaxin11 to 
CD3 shown on the right. Scale bar: 5 µm. 
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Figure 24: Colocalization analysis of recycling endosomes, Syntaxin11 and TCR 
Quantification of the overlap between recycling endosomes, Syntaxin11 and TCR, using Mander’s coefficient of 
colocalization. Bar graphs represent the strong overlap between (A) Syntaxin11 to Rab11a, (B) CD3 to Rab11a and 
(C) CD3 to Syntaxin11. Error bars are SEM.  
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4. DISCUSSION 
We have examined the role of the protein Syntaxin11 in CTL function. Mutations within 
Syntaxin11 result in a disease called FHL that is the result of CTL dysfunction. We show 
that Syntaxin11 is the t-SNARE that is required for the final step of LG fusion at the IS. 
Downregulation of Syntaxin11 expression by RNA interference (RNAi) led to a dramatic 
reduction in LG fusion at the IS concomitant with reduction in LG dwell time. RNAi 
treatment of primary human CTLs is a reliable method to study the mechanism of CTL 
function, since the phenotype is associated with FHL-4: reduced LAMP1a degranulation 
and CTL mediated target cell cytotoxicity. 
We finally show that Syntaxin11 is colocalized with TCR/CD3 containing endosomal 
compartments which are delivered to the IS through Rab11a containing recycling 
endosomes (Figure 25 A, B and C). 
 
4.1 SNARE proteins and the immune system 
A newly synthesized protein must be transported to its respective target destination by 
intracellular trafficking processes. In immune cells, which are primarily secretory in 
function, release of proteins as messengers or effectors is also intimately tied to 
trafficking. SNARE proteins are the main players of intracellular trafficking since they 
are required for fusion of compartments which generates storage organelles and allows 
newly synthesized proteins to reach secretory vesicles (Stow et al., 2006). There are 
several other protein families that are also involved in trafficking and vesicle transport, 
such as the Rab GTPases, tethering factors and escort proteins  
Loss of Syntaxin11 causes FHL-4, an immune disease with severe clinical 
manifestations (Bryceson et al., 2007; Danielian et al., 2010; zur Stadt et al., 2005). 
Other subtypes of FHL include FHL-2 (Feldmann et al., 2002; Horne et al., 2008) , FHL-
3 (Feldmann et al., 2003) and recently identified FHL-5 (Cetica et al., 2010; Cote et al., 
2009; zur Stadt et al., 2009). Major clinical symptoms (Section 1.9) include high levels 
of soluble IL-2 receptor in blood, less frequent central nervous system involvement; over 
activated macrophages, histiocytes and T cells with defective CTL and NK cell 
cytotoxicity, hemophagocytosis in bone marrow, cerebrospinal fluid or lymphonodes by 
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activated histiocytes and coagulopathy (Zhang et al., 1993; Zhizhuo et al., 2012; Zur 
Stadt et al., 2006).  
FHL is due to uncontrolled activation or proliferation of effector cells (NK cell and CTLs), 
macrophages and histiocytes, due to inefficient eradication of pathogens or infections. 
This leads to an over production of cytokines resulting in hyperactivation of 
macrophages, which in turn leads to infiltration of tissues or organs by macrophages 
and eventual destruction of organs such as the liver and spleen (Horne et al., 2008; 
Janka, 1983). 
Patients suffering from FHL have high serum levels of IFN-γ, TNF-α, interleukin IL-6, IL-
8, IL-10, IL-12, IL-18 and macrophage inflammatory protein (MIP)-1α. Cytokines may 
also infiltrate tissues and promoting necrosis and organ failure. Fever and cytopenias 
are prominent in FHL and may be induced by several cytokines, such as TNF, IL-6 and 
IFN-γ. TNF also has a procoagulant activity, which accounts for hypofibrinogenaemia. 
Hypertriglyceridaemia is associated with reduced lipoprotein lipase (Janka, 2007; Osugi 
et al., 1997). 
Identification of the molecular defects associated with FHL gives insight into the 
mechanisms by which pathology occurs. Congenital defects associated with either 
impaired perforin synthesis or any defect in perforin function results in FHL-2. Perforin is 
a 67 kDa protein stored in conjunction with Granzymes (a group of serine proteases) in 
secretory lysosomes or mature LGs in NK cells and CTLs. These proteins are released 
simultaneously at the IS through exocytosis. Upon release, perforin polymerizes and 
generates transmembrane pores in target cell membrane of about 10-20 nm in diameter 
through which granyzmes can enter the target cell in order to induce apoptosis 
(Voskoboinik et al., 2006). Some of the missense mutations in PRF1 gene result in a 
conformational change within the perforin molecule which prevents proteolytic cleavage 
of perforin precursors into functional perforin. As a result, the functional form of the 
protein is absent, resulting in serious consequences (Risma et al., 2006). 
Another form of FHL, FHL-3 is due to mutations of Munc13-4, thought to be the priming 
factor for LGs in NK cells and CTLs. FHL-3 accounts for 20% - 30% of all FHL cases 
(Janka, 2007). The Munc13 protein family includes Munc13-1, Munc13-2, Munc13-3 
and Munc13-4. Munc13s have characteristic C2 domains and MHD domains, required 
for vesicle priming. Munc13-4 is believed to be an effector for Rab27a, a protein directly 
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associated with Griscelli syndrome type 2 (GS2) (See section 1.9). Mutations within 
Munc13-4 and Rab27a can disrupt the interaction between the two proteins and this 
disrupts their ability to promote fusion. The Munc13-4*Rab27a complex interaction is 
not required for maturation of secretory lysosomes (LGs) rather it is necessary for 
tethering of the LGs to plasma membrane. Moreover, the Munc13-4*Rab27a complex 
enhances the stability the SNARE complex required for the fusion of the LGs (Elstak et 
al., 2012; Elstak et al., 2011; Neeft et al., 2005). Elevated levels of perforin molecules 
have been reported in the CTLs of FHL-3 patients, consistent with LG priming defects 
(Bryceson et al., 2007). In vitro studies have shown that Munc13-4 promotes Ca2+- 
dependent SNARE complex formation and SNARE-mediated liposome fusion. These 
properties of Munc13-4 led to the suggestion that it functions as a Ca2+ sensor which 
modulates priming, the rate-limiting step in granule exocytosis (Boswell et al., 2012).  
Recently another form of FHL (FHL-5) has been associated with mutations in STXBP2 
encoding Syntaxin binding protein 2 (Munc18-2) a protein involved in the regulation of 
intracellular trafficking which also controls SNARE complex assembly. Studies with 
FHL-5 patient samples showed that mutations within Munc18-2, completely disrupt its 
ability to interact with Syntaxin11, thus leading to a defect at the final step of cytotoxic 
granule secretion (Cote et al., 2009; zur Stadt et al., 2009). 
Involvement of Syntaxin11 in FHL-4 is well established on the basis of defective 
degranulation and cytotoxicity in patients carrying mutations within the coding region of 
Stx11 gene. However, degranulation and cytotoxicity can be partially reconstituted using 
high doses of recombinant IL-2 treatment in FHL-3 and FHL-4 patient samples 
(Bryceson et al., 2007; Horne et al., 2008; Schneider et al., 2002). 
 
4.2 Syntaxin11 and LGs: direct or indirect interaction  
Inherited defects in immune function associated with mutations within the coding region 
of Syntaxin11 indicate an important role in immune cells. Syntaxin11 is expressed in 
neutrophils and is upregulated when neutrophils differentiate. This has been shown 
using the neutrophil differentiation marker CD11b at both the mRNA and protein levels 
(Xie et al., 2009), Syntaxin11 is expressed in monocytes and macrophages 
(Offenhauser et al., 2011; zur Stadt et al., 2005), Syntaxin11 is also expressed in NK 
cells (Dabrazhynetskaya et al., 2012). In our study, we show that Syntaxin11 is 
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expressed in CD8+ cells and its expression is upregulated 3 folds upon stimulation 
which we confirmed with qRT-PCR (Figure 7). This result is consistent with studies on 
other immune cells which also show specific upregulation of certain SNAREs upon cell 
activation (Murray et al., 2005). Since, it is known that, mutations in Syntaxin11 results 
in defective degranulation, as previously shown in FHL-4 patient samples (Bryceson et 
al., 2007). We began our study with the degranulation assay which is an indirect 
measure of LG exocytosis. CTLs were treated with Syntaxin11 specific siRNA to knock 
down endogenous Syntaxin11 expression. We found that, Syntaxin11 knockdown led to 
a 76 % (Figure 9 C) reduction in LAMP1a degranulation in CTLs. 
We confirmed these results using an independent approach to test the ability of CTLs 
for target cell cytotoxicity. Based on previous observations (Bryceson et al., 2007; 
D'Orlando et al., 2012), Syntaxin11 involvement in cytotoxicity is evident and over 
expression of Syntaxin11 in NK cells led to significant increase in the killing of the NK-
sensitive tumor targets, 721 and K562 cells. Decreased expression of Syntaxin11 
(knockdown studies using siRNA) reduced cytotoxicity in NK cells (Arneson et al., 
2007).  
We observed a severe defect in the ability of CTLs to kill target cells after Syntaxin11 
expression was reduced, in contrast to control siRNA treated CTLs (Figure 10). This 
effect is specific for Syntaxin11 knockdown.  
Based on our results showing defective LAMP1a degranulation and target cell 
cytotoxicity in CTLs that were knocked down for Syntaxin11, we used TIRFM to 
specifically look at the behavior of the LGs at the PM (Pattu et al., 2011). 
The observation that loss of Syntaxin11 leads to FHL-4 led to speculation about a role 
for Syntaxin11 in CTLs and NK cells. However, the lack of appropriate high resolution 
techniques, has limited the progress in identifying the site where Syntaxin11 functions. 
We show that there are observable changes in LG behavior in real time, using 
evanescent wave microscopy (TIRFM) (Pattu et al., 2011). TIRFM allows us to visualize 
the events prior to fusion at the plasma membrane such as docking and priming, in 
addition to fusion.  
Our TIRFM experiments in CTLs using Syntaxin11 siRNA, reveal a dramatic reduction 
in the fusion of LGs in CTLs. This result is in agreement with the results of LAMP1a 
degranulation and target cell cytotoxicity assay (Figure 9, 10). Further analysis revealed 
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that the LGs are unable to fuse at the IS, mainly because of defect in LG docking as 
confirmed by the dwell time analysis of LGs (Figure 12 B). The LGs failed to fuse at the 
IS in CTLs which are knocked down for Syntaxin11 (Figure 11 B). 
 
4.3 Syntaxin11, a target SNARE for the fusion of LGs  
Based on our findings we confirm that Syntaxin11 is not involved in LG maturation steps 
or in endosomal maturation. Syntaxin11 has been reported to be localized to TGN 
(Trans-Golgi network) and late endosomes in Hela cells (Tang et al., 1998a; Valdez et 
al., 1999), TGN and Cis-Golgi complex (Prekeris et al., 2000), specific tertiary granules 
in neutrophils (Xie et al., 2009), the plasma membrane in NK cells and CTLs (Arneson 
et al., 2007), growth hormone (GH) containing granules in GH producing cell line MtT/S 
cells (Kawashima et al., 2010), post Golgi in normal rat kidney cells (NRK cells) (Advani 
et al., 1998), plasma membrane in macrophages (Zhang et al., 2008), localized to 
mannose 6- phosphate receptor (M6PR) intracellular compartments, Rab27a positive 
vesicles and cytotoxic granules in NK cells (Dabrazhynetskaya et al., 2012), late 
endosomes and lysosomes in macrophages (Offenhauser et al., 2011).  
Based on the functional studies in FHL-4 patient samples (zur Stadt et al., 2005), 
Syntaxin11 KO mouse (D'Orlando et al., 2012) and localization studies, it was proposed 
that Syntaxin11 mediates the fusion between late endosomes and lysosomes in 
macrophages (Offenhauser et al., 2011) and M6PR positive vesicles containing Rab27a 
and cytotoxic granules in NK cells (Dabrazhynetskaya et al., 2012). A role for 
Syntaxin11 in platelet secretion (Ye et al., 2012) and LG secretion in CTLs has been 
reported (Arneson et al., 2007; Bryceson et al., 2007; D'Orlando et al., 2012). 
Syntaxin11 has been proposed as the t-SNARE on the plasma membrane for the  
fusion of LGs at the IS (de Saint Basile et al., 2010; Hong, 2005). 
 
A functional SNARE complex includes four SNARE helical bundles contributed by three 
cognate SNARE partners, typically Syntaxin, SNAP and synaptobrevin (Section 1.8 and 
1.10). Members of the Syntaxin family belong to the prototype family of SNARE 
proteins, which have a characteristic trans-membrane domain at the carboxy-terminal 
end for anchoring to the plasma membrane attached to a coiled-coil domain by a short 
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linker. There are 15 members of the Syntaxin family in the human genome (Teng et al 
2001).  
The striking reduction of LG fusion (Figure 11) and dwell time (Figure 12) after knock 
down of Syntaxin11 provoked us to look at the association between LGs and 
Syntaxin11. To do so, we overexpressed CTLs with mCherry-Syntaxin11 along with the 
LG marker; Granzyme B-TFP and imaged them in TIRFM. We saw a strong overlap 
between Syntaxin11 clusters and LGs at the TIRF plane (at the IS).  
Similar clusters of Syntaxin1A, the t-SNARE for synaptic vesicle fusion in neurons, have 
been reported in neurons. Other detailed studies of Syntaxin clusters at the plasma 
membrane or in cell free (in-vitro) systems have shown the interaction between 
Syntaxin and single secretory granules by dual color TIRFM in other cell types (Bar-On 
et al., 2009; Barg et al., 2010). Barg et al., (2010) showed that Syntaxin-GFP 
assembled in clusters at sites where single granules had docked at the plasma 
membrane. These clusters were intermittently present at granule sites, as Syntaxin 
molecules assembled and disassembled in a coordinated fashion. The clusters 
facilitated exocytosis and disassembled once exocytosis was complete. Syntaxin cluster 
formation defines an intermediate step in exocytosis. Further this Syntaxin clustering is 
mediated by electrostatic interactions with the strongly anionic lipid phosphatidylinositol-
4, 5 - bisphosphate (PIP2) (van den Bogaart et al., 2009). Apart from Syntaxin1 A, 
clustering of other Syntaxins like Syntaxin3 and 4 have been reported in other cells 
(Low et al., 2006).  
In agreement with the findings described above and based on our results, it is clear that 
in CTLs Syntaxin11 has a tendency to form clusters at the membrane, thus creating 
hotspots for the arriving LGs to fuse at the plasma membrane (Figure 14, 25 B and 25 
C). Moreover, these findings provide clear evidence that Syntaxin11 functions as the 
only t-SNARE for LG fusion at the IS. These findings are supported by analysis of the 
average fluorescence intensity over time for both the Syntaxin11 clusters and the LGs 
at the IS (Figure 16). The fluorescence of Syntaxin11 always remained higher than that 
of the LGs at the IS. This phenomenon is in agreement with other reports that 
demonstrate a typical t-SNARE behavior on the PM (Bar-On et al., 2009; Barg et al., 
2010). In our TIRF experiments with Syntaxin11 and LGs, as described in figure 14, we 
observed a strong overlap between the Syntaxin11 clusters and LGs, but, due to the 
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very narrow time window or time gap between the Syntaxin11 and LGs arrival, it was 
not possible to differentiate between the arrival of Syntaxin11 and LGs at the IS. We 
suggest that Syntaxin11 is the t-SNARE for lytic granule fusion. If this is true, 
Syntaxin11 should arrive at the IS prior to the arrival of LGs. We turned to live cell 
imaging to address the question of the arrival timing of Syntaxin11 and LGs at the IS. 
We used CTLs overexpressing TFP-Syntaxin11 and the LG marker Granzyme B-
mCherry and imaged the cell before, during and after target cell contact. The pattern of 
distribution for Syntaxin11 positive compartments is completely different from those of 
LGs and TCR positive compartments. Interestingly, Syntaxin11 expression is abundant 
and exclusively in the polarizing end of the CTL i.e. uropods while the LGs are observed 
in the trailing part of the cell. Once the resting CTL recognizes its target cell, the CTL 
reorients itself completely towards the target cell. Immediately after target cell contact, 
Syntaxin11 positive cargo vesicles are delivered to the IS. Since, Syntaxin11 is the t-
SNARE for LG fusion, it is expected to be delivered to the IS before LGs. After the CTL 
establishes firm contact with the target cell, the final step of LG polarization to the IS 
and fusion occur. The lethal hit occurs at the sites where the Syntaxin11 has 
accumulated. We observed the same phenomenon by both TIRFM on antibody coated 
glass coverslips (Figure 14) and by live imaging with target cells (Figure17).  
 
4.4 In which compartments does Syntaxin11 reside? 
 Rab11a positive recycling endosomal compartments are known for their role in 
trafficking of Munc13-4 to the IS. We examined the association between Rab11a and 
the Syntaxin11 positive compartments. In our colocalization analysis, we observed a 
partial overlap of Syntaxin11 with Rab11a; Mander’s colocalization coefficient = 0.8 ± 
0.006 and of Rab11a with Syntaxin11; Mander’s colocalization coefficient = 0.2 ± 
0.006). Imaging in TIRFM showed a strong correlation between Rab11a and Syntaxin11 
in TIRFM (Figure 20), this overlap was seen only in the Rab11a positive vesicles seen 
early in the experiment, providing evidence that these vesicles bring the Syntaxin11 
molecules to the IS (Figure 25 A). 
There was a strong overlap of fluorescence (Figure 22), but the fluorescence signal of 
Syntaxin11 remained constant throughout the acquisition in contrast to Rab11a, which 
showed an exponential increase. This is in line with the role of recycling endosomes in 
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delivery of components required for IS formation, the fluorescent signal of Syntaxin11 
remains unchanged throughout the acquisition. This can be explained by the limited 
number of t-SNAREs that are delivered to the IS. The t-SNARE availability could control 
the number of LG fusion events per target cell.  
 
4.5 Relevance of TCR/CD3 association with Syntaxin11 and the IS  
We have defined the vesicles positive for both Syntaxin11 and Rab11a. Recycling 
TCR/CD3 complexes are an essential part of recycling endosomes and behave similarly 
to Rab11a positive recycling endosomes. The TCR gene has different subunits; TCR 
alpha, beta, gamma and delta. In thymus, T lymphocytes are classified based on which 
TCR complex they express on their surface. CD8+ cells found in the thymus are either 
TCR alpha-beta cells or TCR gamma-delta cells (Correale et al., 1997). Similarly, CD3 
occurs in different subunits, also called chains (gamma, delta- and epsilon-chain) 
(Clevers et al., 1988; Kearse et al., 1995). 
We performed TIRF experiments using CTLs transfected with CD3e along with the 
Syntaxin11 and Rab11a. Interestingly, we found a significant amount of colocalization 
between intracellular CD3e positive compartments and Syntaxin11 compartments 
(Mander’s colocalization; CD3e to Syntaxin11 = 0.8, Syntaxin11 overlapping CD3e = 
0.8). Since Rab11a shows partial overlap with CD3e (Mander’s colocalization; CD3e to 
Rab11a = 0.72; n=8, Rab11a overlapping CD3e = 0.17; n=8), this is in accordance with 
our results depicting a partial overlap between Syntaxin11 and Rab11a compartments. 
Therefore, based on our results, we conclude that a subpopulation of Rab11a 
containing recycling endosomes that contains TCR/CD3e/Syntaxin11, delivers the 
Syntaxin11 to the IS as depicted in the figure below (Figure 25 A).  
Based on our results obtained in this study, we postulate a model that depicts the 
involvement of Rab11a recycling endosomes in bringing TCR/CD3 complexes along 
with Syntaxin11 to the IS (Figure 25 A). This results in the formation of Syntaxin11 
clusters, hotspots for SNARE dependent LG fusion (Figure 25 B and C).    
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Figure 25: The fusion of LGs at the hotspots containing Syntaxin11 clusters  
(A) TCR/CD3 containing endosomes fuse with Syntaxin11 containing recycling endosomes via early endosomes (EE) 
and late endosomes (LE).They are then delivered to the IS, thus stabilizing the IS for LGs arrival. (B) LGs dock, prime 
and fuse at the hotspots that contain Syntaxin11 clusters (t-SNARE). through either from lysosomes (LS) or from LEs, 
arrives at the hotspots containing Syntaxin11 clusters (t-SNARE) for fusion at the IS. (C) Syntaxin11 along with 
cognate SNARE partners, Synaptobrevin (blue) and SNAP (yellow) mediates the final fusion of LGs at the 
immunological synapse.  
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5. OUTLOOK 
Elucidation of the function of Syntaxin11 in LG fusion at the IS, furthers our 
understanding of CTL function. Though a number of questions remain, the pivotal role 
of Syntaxin11 in T cells provides a potential target for future therapy, including the 
possibility of gene therapy replacement of Syntaxin11.  
As discussed above Syntaxin11 has already received much attention in T cells, in 
mouse models of FHL-4, knockout of Syntaxin11 does not reproduce the lethality or 
phenocopy of FHL-4, unless Syntaxin11 KO mice are challenged with viral infections. It 
is likely that this difference is due to the lack of pathogen challenge in mouse models. 
This possibility should be addressed. In addition, the possibility of redundancy and/or 
promiscuity of various Syntaxins in CTLs must also be addressed. 
Based on all the facts discussed above and in line with Bryceson et al (2007), we 
speculate that the severity of FHL-4 is much less when compared to FHL-2 and 3. 
Reconstitution of FHL-4 defects by substituting with recombinant IL-2 could be because 
there are some redundant SNARE proteins which compensate for Syntaxin11 function 
or that IL-2 stimulation induces a Syntaxin11 independent lytic granule degranulation 
pathway. 
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6. SUMMARY 
We elucidate the molecular mechanism of lytic granule fusion in CTLs by identifying the 
Syntaxin11 as a t-SNARE for LG exocytosis. We knockdown the expression of 
Syntaxin11 in CTLs and showed that there is a strong reduction in LG fusion at the IS 
that is accompanied by a reduction in the dwell time of LGs at the plasma membrane. In 
agreement with the reported phenotype in FHL-4 and Syntaxin11 KO mice, we showed 
that CTLs treated with Syntaxin11 siRNA show reduced degranulation. In addition, 
these CTLs fail to kill target cells. Using high resolution microscopic techniques we 
show that Syntaxin11 moves from in intracellular compartments along with recycling 
TCRs, to the IS, in Rab11a positive recycling endosomes. The trafficking of Syntaxin11 
along with TCRs clearly demonstrates that LG polarization towards the IS is a 
completely independent process that occurs after recycling endosomes have built a 
functional IS by bringing in all the essential early components for IS formation. 
Therefore, TCR-CD3 complexes, which strengthen the IS and the t-SNARE, 
Syntaxin11, which docks arriving LGs, polarize to the IS prior to LGs delivery. 
Thus, we show that Syntaxin11 is not involved in the maturation steps of LGs or of any 
other intracellular compartment. This disproves all earlier reports indicating an 
involvement of Syntaxin11 in LG maturation steps. This conclusion is supported by 
TIRFM, fusion analysis and dwell time analysis, in which we show that there is no 
significant change in the number of LGs at the IS. 
Our study gives new insights into the mechanisms of CTL mediated cytotoxicity. Our 
results answer the molecular basis of FHL-4, a genetic disorder resulting in a defect in 
CTL function, caused by mutations in Syntaxin11.  
 
 
 
 
 
 
---------- Literature ---------- 
- 70 - 
 
7. LITERATURE 
Abbas, A. K., Lichtman, A. H., (2007). Basics of immunology. 3rd Edition, Saunders 
ELSEVIER. 
 
Advani, R. J., Bae, H. R., Bock, J. B., Chao, D. S., Doung, Y. C., Prekeris, R., Yoo, J. S. 
and Scheller, R. H. (1998). Seven novel mammalian SNARE proteins localize to distinct 
membrane compartments. J Biol Chem 273, 10317-10324. 
 
Andersen, M. H., Schrama, D., Thor Straten, P. and Becker, J. C. (2006) Cytotoxic T 
cells. J Invest Dermatol 12, 32-41. 
 
Arneson, L. N., Brickshawana, A., Segovis, C. M., Schoon, R. A., Dick, C. J. and 
Leibson, P. J. (2007). Cutting edge: Syntaxin 11 regulates lymphocyte-mediated 
secretion and cytotoxicity. J Immunol 179, 3397-3401. 
 
Baetz, K., Isaaz, S. and Griffiths, G. M. (1995). Loss of cytotoxic T lymphocyte function 
in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule 
exocytosis. J Immunol 154, 6122-6131. 
 
Bar-On, D., Gutman, M., Mezer, A., Ashery, U., Lang, T. and Nachliel, E. (2009). 
Evaluation of the heterogeneous reactivity of the Syntaxin molecules on the inner leaflet 
of the plasma membrane. J Neurosci 29, 12292-12301. 
 
Barg, S., Knowles, M. K., Chen, X., Midorikawa, M. and Almers, W. (2010). Syntaxin 
clusters assemble reversibly at sites of secretory granules in live cells. Proc Natl Acad 
Sci U S A 107, 20804-20809. 
 
Barnard, R. J., Morgan, A. and Burgoyne, R. D. (1996). Domains of alpha-SNAP 
required for the stimulation of exocytosis and for N-ethylmalemide-sensitive fusion 
protein (NSF) binding and activation. Mol Biol Cell 7, 693-701. 
 
---------- Literature ---------- 
- 71 - 
 
Barry, M., and Bleackley, C. (2002). Cytotoxic T lymphocytes: all roads lead to death. 
Nat Rev Immunol 2, 401-9. 
 
Becherer, U., Medart, MR., Schirra, C., Krause, E., Stevens, D., and Rettig, J. (2012). 
Regulated exocytosis in chromaffin cells and cytotoxic T lymphocytes: how similar are 
they? Cell Calcium 52, 303-12. 
 
Bennett, M. K., Garcia-Arraras, J. E., Elferink, L. A., Peterson, K., Fleming, A. M., 
Hazuka, C. D. and Scheller, R. H. (1993). The Syntaxin family of vesicular transport 
receptors. Cell 74, 863-873. 
 
Billadeau, D. D., Nolz, J. C. and Gomez, T. S. (2007). Regulation of T-cell activation by 
the cytoskeleton. Nat Rev Immunol 7, 131-143. 
 
Bock, J. B., Matern, H. T., Peden, A. A. and Scheller, R. H. (2001). A genomic 
perspective on membrane compartment organization. Nature 409, 839-841. 
 
Bogaart, G., Meyenberg, K., Risselada, H. J., Amin, H., Diederichsen, U. and Jahn, R. 
(2009). Membrane protein sequestering by ionic protein-lipid interactions. Nature 479, 
552-555. 
 
Boswell, K. L., James, D. J., Esquibel, J. M., Bruinsma, S., Shirakawa, R., Horiuchi, H. 
and Martin, T. F. (2012). Munc13-4 reconstitutes calcium-dependent SNARE-mediated 
membrane fusion. J Cell Biol 197, 301-312. 
 
Bousso, E. A. R. (2004). Dynamic Behavior of T Cells and Thymocytes in Lymphoid 
Organs as Revealed by Two-Photon Microscopy. Immunity 3, 349-55 
 
Bromley, S. K. and Dustin, M. L. (2002). Stimulation of naïve T-cell adhesion and IS 
formation by chemokine-dependent and -independent mechanisms. Immunology 106, 
289-298. 
 
---------- Literature ---------- 
- 72 - 
 
Brose, N., Hofmann, K., Hata, Y. and Sudhof, T. C. (1995). Mammalian homologues of 
Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins. J Biol 
Chem 270, 25273-25280. 
 
Bryceson, Y. T., Rudd, E., Zheng, C., Edner, J., Ma, D., Wood, S. M., et al. (2007). 
Defective cytotoxic lymphocyte degranulation in Syntaxin-11 deficient familial 
hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 110, 1906-1915. 
 
Cemerski, S. and Shaw, A. (2006). Immune synapses in T-cell activation. Curr Opin 
Immunol 18, 298-304. 
 
Cetica, V., Santoro, A., Gilmour, K. C., Sieni, E., Beutel, K., Pende, D., Marcenaro, S., 
Koch, F., Grieve, S., Wheeler, R., et al. (2010). STXBP2 mutations in children with 
familial haemophagocytic lymphohistiocytosis type 5. J Med Genet 47, 595-600. 
 
Chen, Y. A. and Scheller, R. H. (2001). SNARE-mediated membrane fusion. Nat Rev 
Mol Cell Biol 2, 98-106. 
 
Clevers, H., Alarcon, B., Wileman, T. and Terhorst, C. (1988). The T cell receptor/CD3 
complex: a dynamic protein ensemble. Annu Rev Immunol 6, 629-662. 
 
Correale, J., Rojany, M. and Weiner, L. P. (1997). Human CD8+ TCR-alpha beta(+) and 
TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific 
CD4+ T-cells by different mechanisms. J Neuroimmunol 80, 47-64. 
 
Cote, M., Menager, M. M., Burgess, A., Mahlaoui, N., Picard, C., Schaffner, C., et al. 
(2009). Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 
and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 119, 3765-
3773. 
 
---------- Literature ---------- 
- 73 - 
 
D'Orlando, O., Zhao, F., Kasper, B., Orinska, Z., Muller, J., Hermans-Borgmeyer, I., et 
al. (2012). Syntaxin 11 is required for NK and CD8(+) T-cell cytotoxicity and neutrophil 
degranulation. Eur J Immunol. 43, 194-208 
 
Dabrazhynetskaya, A., Ma, J., Guerreiro-Cacais, A. O., Arany, Z., Rudd, E., Henter, J. I, 
et al. (2012). Syntaxin 11 marks a distinct intracellular compartment recruited to the IS 
of NK cells to colocalize with cytotoxic granules. J Cell Mol Med 16, 129-141. 
 
Danielian, S., Basile, N., Rocco, C., Prieto, E., Rossi, J., Barsotti, D., et al. (2010). 
Novel Syntaxin 11 gene (STX11) mutation in three Argentinean patients with 
hemophagocytic lymphohistiocytosis. J Clin Immunol 30, 330-337. 
 
de Saint Basile, G., Menasche, G. and Fischer, A. (2010). Molecular mechanisms of 
biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol 10, 568-579. 
 
Delon, J., Kaibuchi, K. and Germain, R. N. (2001). Exclusion of CD43 from the IS is 
mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. 
Immunity 15, 691-701. 
 
Eisenbarth, S. C. and Flavell, R. A. (2009). Innate instruction of adaptive immunity 
revisited: the inflammasome. EMBO Mol Med 1, 92-98. 
 
Elstak, E. D., Neeft, M., Nehme, N. T., Callebaut, I., de Saint Basile, G. and van der 
Sluijs, P. (2012). Munc13-4*rab27 complex tethers secretory lysosomes at the plasma 
membrane. Commun Integr Biol 5, 64-67. 
 
Elstak, E. D., Neeft, M., Nehme, N. T., Voortman, J., Cheung, M., Goodarzifard, M., et 
al. (2011). The Munc13-4-rab27 complex is specifically required for tethering secretory 
lysosomes at the plasma membrane. Blood 118, 1570-1578. 
 
Finetti, F. and Baldari. (2009). Intraflagellar transport is required for polarized recycling 
of the TCR/CD3 complex to the immune synapse. Nat Cell Biol.11, 1332-1339. 
---------- Literature ---------- 
- 74 - 
 
Fais, S. and Malorni, W. (2003). Leukocyte uropod formation and 
membrane/cytoskeleton linkage in immune interactions. J Leukoc Biol 73, 556-563. 
 
Fasshauer, D., Eliason, W. K., Brunger, A. T. and Jahn, R. (1998a). Identification of a 
minimal core of the synaptic SNARE complex sufficient for reversible assembly and 
disassembly. Biochemistry 37, 10354-10362. 
 
Fasshauer, D., Sutton, R. B., Brunger, A. T. and Jahn, R. (1998b). Conserved structural 
features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-
SNAREs. Proc Natl Acad Sci U S A 95, 15781-15786. 
 
Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., et al. (2003). 
Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial 
hemophagocytic lymphohistiocytosis (FHL3). Cell 115, 461-473. 
 
Feldmann, J., Le Deist, F., Ouachee-Chardin, M., Certain, S., Alexander, S., Quartier, 
P., et al. (2002). Functional consequences of perforin gene mutations in 22 patients with 
familial haemophagocytic lymphohistiocytosis. Br J Haematol 117, 965-972. 
 
Gay, D., Sekaly, R., Talle, MA., Godfrey, M., Long, E,. Goldstein, G., et al. (1987). 
Functional interaction between human T-cell protein CD4 and the major 
histocompatibility complex HLA-DR antigen. Nature. 328:626-9. 
 
Garvin, SE., Koretzky, GA., and Jordan, MS. (2009). T Cell Activation. Annu Rev 
Immunol. 27:591-619 
 
Geisler, C. (2004). TCR trafficking in resting and stimulated T cells. Crit Rev Immunol 
24, 67-86. 
 
Goldsby, R. A., Kindt, T. L., (2000). Kuby Immunology. 4th Edition, W H Freeman & Co 
(Sd).  
 
---------- Literature ---------- 
- 75 - 
 
Hahn, S., Gehri, R,. and Erb, P. (1995). Mechanism and biological significance of CD4-
mediated cytotoxicity. Immunol Rev 146, 57-79. 
 
Hatsuzawa, K., Hirose, H., Tani, K., Yamamoto, A., Scheller, R. H. and Tagaya, M. 
(2000). Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, 
intermediate compartment and cis-Golgi vesicle trafficking. J Biol Chem 275, 13713-
13720. 
 
Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Sudhof, T. C. and 
Niemann, H. (1994). Synaptic vesicle membrane fusion complex: action of clostridial 
neurotoxins on assembly. Embo J 13, 5051-5061. 
 
Helgason, C. D., Prendergast, J. A., Berke, G. and Bleackley, R. C. (1992). Culture 
hybridomas are cytolytic in the absence of cytotoxic cell proteinases and perforin. Eur J 
Immunol. 22, 3187–3190  
 
Henter, J. I., Arico, M., Elinder, G., Imashuku, S. and Janka, G. (1998). Familial 
hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. 
Hematol Oncol Clin North Am 12, 417-433. 
 
Hong, W. (2005). Cytotoxic T lymphocyte exocytosis: bring on the SNAREs! Trends Cell 
Biol 15, 644-650. 
 
Horne, A., Ramme, K. G., Rudd, E., Zheng, C., Wali, Y., al-Lamki, Z., et al. (2008). 
Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in 
familial hemophagocytic lymphohistiocytosis. Br J Haematol 143, 75-83. 
 
Huppa, J. B. and Davis, M. M. (2003). T-cell-antigen recognition and the IS. Nat Rev 
Immunol 3, 973-983. 
 
---------- Literature ---------- 
- 76 - 
 
Hurez, V., Saparov, A., Tousson, A., Fuller, M. J., Kubo, T., Oliver, J., et al. (2003). 
Restricted clonal expression of IL-2 by naïve T cells reflects differential dynamic 
interactions with dendritic cells. J Exp Med 198, 123-132. 
 
Jahn, R., Lang, T. and Sudhof, T. C. (2003). Membrane fusion. Cell 112, 519-533. 
Janka, G. E. (1983). Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140, 
221-230. 
 
Janka, G. E. (2007). Familial and acquired hemophagocytic lymphohistiocytosis. Eur J 
Pediatr 166, 95-109. 
 
Jenkins, M. R., Tsun, A., Stinchcombe, J. C. and Griffiths, G. M. (2009). The strength of 
T cell receptor signal controls the polarization of cytotoxic machinery to the IS. Immunity 
31, 621-631. 
 
Jewell, J. L., Oh, E. and Thurmond, D. C. (2010). Exocytosis mechanisms underlying 
insulin release and glucose uptake: conserved roles for Munc18c and Syntaxin 4. Am J 
Physiol Regul Integr Comp Physiol 298, R517-531. 
 
Kawashima, R., Ikematsu, K., Abe, Y., Sato, M., Tsuruya, S., Nakasono, I., et al, (2010). 
Effect of glucocorticoid on the biosynthesis of growth hormone-containing secretory 
granules in pituitary cells. Biochem Biophys Res Commun 400, 225-229. 
 
Kearse, K. P., Roberts, J. L. and Singer, A. (1995). TCR alpha-CD3 delta epsilon 
association is the initial step in alpha beta dimer formation in murine T cells and is 
limiting in immature CD4+ CD8+ thymocytes. Immunity 2, 391-399. 
 
Kennedy, M. J., Davison, I. G., Robinson, C. G. and Ehlers, M. D. (2010). Syntaxin-4 
defines a domain for activity-dependent exocytosis in dendritic spines. Cell 141, 524-
535. 
 
Kesavan, J., Borisovska, M. and Bruns, D. (2007). v-SNARE actions during Ca(2+)-
triggered exocytosis. Cell 131, 351-363. 
---------- Literature ---------- 
- 77 - 
 
Krammer, P. H. (2000). CD95's deadly mission in the immune system. Nature 12, 789-
95. 
 
Kummerow, C., Junker, C., Kruse, K., Rieger, H., Quintana, A. and Hoth, M. (2009). 
The IScontrols local and global calcium signals in T lymphocytes. Immunol Rev, 
231.132-47. 
 
Li, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O'Brien, E. P., et al. (2003). 
Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member 
of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 35, 
84-89. 
 
Logan, M. R., Odemuyiwa, S. O. and Moqbel, R. (2003). Understanding exocytosis in 
immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin 
Immunol 111, 923-932. 
 
Lopez, J. A. and Voskoboinik, I. (2013). Deciphering the syntax of cytotoxic lymphocyte 
degranulation. Eur J Immunol 43, 46-49. 
 
Low, S. H., Vasanji, A., Nanduri, J., He, M., Sharma, N., Koo, M., Drazba, J. and 
Weimbs, T. (2006). Syntaxins 3 and 4 are concentrated in separate clusters on the 
plasma membrane before the establishment of cell polarity. Mol Biol Cell 17, 977-989. 
 
Lowin, B., Beermann, F., Schmidt, A. and Tschopp, J. (1994). A null mutation in the 
perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated 
cytotoxicity. Proc Natl Acad Sci U S A 91, 11571-11575. 
 
Macartney, C. A., Weitzman, S., Wood, S. M., Bansal, D., Steele, M., Meeths, M., et al. 
(2011). Unusual functional manifestations of a novel STX11 frameshift mutation in two 
infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatr Blood 
Cancer 56, 654-657. 
 
---------- Literature ---------- 
- 78 - 
 
Marsh, R. A., Satake, N., Biroschak, J., Jacobs, T., Johnson, J., Jordan, M. B., et al. 
(2010). STX11 mutations and clinical phenotypes of familial hemophagocytic 
lymphohistiocytosis in North America. Pediatr Blood Cancer 55, 134-140. 
 
Menager, M. M., Menasche, G., Romao, M., Knapnougel, P., Ho, C. H., Garfa., et al. 
(2007). Secretory cytotoxic granule maturation and exocytosis require the effector 
protein hMunc13-4. Nat Immunol 8, 257-267. 
 
Menasche, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., et al. 
(2000). Mutations in RAB27A cause Griscelli syndrome associated with 
haemophagocytic syndrome. Nat Genet 25, 173-176. 
 
Mentlik, K. B., Sanborn, E. L., Holzbaur, a. and Orange, J. S. (2010). Rapid Lytic 
Granule Convergence to the MTOC in Natural Killer Cells Is Dependent on Dynein But 
Not Cytolytic Commitment. Mol Biol Cell. 21:2241-56 
 
Muppirala, M., Gupta, V. and Swarup, G. (2011). Syntaxin 17 cycles between the ER 
and ERGIC and is required to maintain the architecture of ERGIC and Golgi. Biol Cell 
103, 333-350. 
 
Murray, R. Z., Wylie, F. G., Khromykh, T., Hume, D. A. and Stow, J. L. (2005). Syntaxin 
6 and Vti1b form a novel SNARE complex, which is up-regulated in activated 
macrophages to facilitate exocytosis of tumor necrosis Factor-alpha. J Biol Chem 280, 
10478-10483. 
 
Nagata, S. (1996). Fas-mediated apoptosis. Adv Exp Med Biol 406, 119-124. 
 
Neeft, M., Wieffer, M., de Jong, A. S., Negroiu, G., Metz, C. H., van Loon, A., et al. 
(2005). Munc13-4 is an effector of rab27a and controls secretion of lysosomes in 
hematopoietic cells. Mol Biol Cell 16, 731-741. 
 
---------- Literature ---------- 
- 79 - 
 
O'Keefe, J. P. and Gajewski, T. F. (2005). Cutting edge: cytotoxic granule polarization 
and cytolysis can occur without central supramolecular activation cluster formation in 
CD8+ effector T cells. J Immunol 175, 5581-5585. 
 
Offenhauser, C., Lei, N., Roy, S., Collins, B. M., Stow, J. L. and Murray, R. Z. (2011). 
Syntaxin 11 binds Vti1b and regulates late endosome to lysosome fusion in 
macrophages. Traffic 12, 762-773. 
 
Ogawa, M. (1993). Differentiation and Proliferation of Hematopoietic Stem Cells. Blood 
81, 2844-53. 
 
Orange, J. S. (2008). Formation and function of the lytic NK‑cell IS. Nat Rev Immunol 8, 
713–725. 
 
Orkin, S. H. (2000). Diversification of haematopoetic stem cells to specific lineages. Nat 
Rev Genetics 1, 57-64. 
 
Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., et al. (1997). 
Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic 
lymphohistiocytosis. Blood 89, 4100-4103. 
 
Pattu, V., Qu, B., Marshall, M., Becherer, U., Junker, C., Matti, U., Schwarz, E. C., 
Krause, E., Hoth, M. and Rettig, J. (2011). Syntaxin7 is required for lytic granule release 
from cytotoxic T lymphocytes. Traffic 7, 890-901 
 
Peter, ME. and Krammert, PH. (1998). Mechanisms of CD95 (APO-1/Fas)-mediated 
apoptosis. Current Opinion in Immunology. 10:545-51. 
 
Prekeris, R., Klumperman, J. and Scheller, R. H. (2000). Syntaxin 11 is an atypical 
SNARE abundant in the immune system. Eur J Cell Biol 79, 771-780. 
 
---------- Literature ---------- 
- 80 - 
 
Prekeris, R., Yang, B., Oorschot, V., Klumperman, J. and Scheller, R. H. (1999). 
Differential roles of Syntaxin 7 and Syntaxin 8 in endosomal trafficking. Mol Biol Cell 10, 
3891-3908. 
 
Qu, B., Pattu, V., Junker, C., Schwarz, E. C., Bhat, S. S., Kummerow, C., et al. (2011). 
Docking of lytic granules at the IS in human CTL requires Vti1b-dependent pairing with 
CD3 endosomes. J Immunol 186, 6894-6904. 
 
Ravichandran, V., Chawla, A. and Roche, P. A. (1996). Identification of a novel 
Syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-
neuronal tissues. J Biol Chem 271, 13300-13303. 
 
Reiner, S. (2009). Decision making during the conception and career of CD4+ T cells. 
Nat Rev Immunol 2, 81-2. 
 
Riento, K., Galli, T., Jansson, S., Ehnholm, C., Lehtonen, E. and Olkkonen, V. M. 
(1998). Interaction of Munc18-2 with Syntaxin 3 controls the association of apical 
SNAREs in epithelial cells. J Cell Sci 111, 2681-2688. 
 
Risma, K. A., Frayer, R. W., Filipovich, A. H. and Sumegi, J. (2006). Aberrant 
maturation of mutant perforin underlies the clinical diversity of hemophagocytic 
lymphohistiocytosis. J Clin Invest 116, 182-192. 
 
Rudd, E., Ericson, K., Zheng, C., Uysal, Z., Ozkan, A., Gurgey, A., et al. (2006). 
Spectrum and clinical implications of Syntaxin 11 gene mutations in familial 
haemophagocytic lymphohistiocytosis: association with disease-free remissions and 
haematopoietic malignancies. J Med Genet 43, e14. 
 
Schmid, P. J., Ho, C. H., Diana, J., Pivert, G., Lehuen, A. and Geissmann, F., et al. 
(2008). A Griscelli syndrome type 2 murine model of hemophagocytic 
lymphohistiocytosis (HLH). Eur J Immunol 38, 3219-3225. 
 
---------- Literature ---------- 
- 81 - 
 
Schneider, E. M., Lorenz, I., Muller-Rosenberger, M., Steinbach, G., Kron, M. and 
Janka-Schaub, G. E. (2002). Hemophagocytic lymphohistiocytosis is associated with 
deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-
cell-induced apoptosis. Blood 100, 2891-2898. 
 
Seabra, M. C. and Wasmeier, C. (2004). Controlling the location and activation of Rab 
GTPases. Curr Opin Cell Biol 16, 451-457. 
 
Shiffman, D., Rowland, C. M., Louie, J. Z., Luke, M. M., Bare, L. A., Bolonick, J. I., et al. 
(2006). Gene variants of VAMP8 and HNRPUL1 are associated with early-onset 
myocardial infarction. Arterioscler Thromb Vasc Biol 26, 1613-1618. 
 
Sieber, J. J., Willig, K. I., Heintzmann, R., Hell, S. W. and Lang, T. (2006). The SNARE 
motif is essential for the formation of Syntaxin clusters in the plasma membrane. 
Biophys J 90, 2843-2851. 
 
Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H. and Rothman, J. E. 
(1993). A protein assembly-disassembly pathway in vitro that may correspond to 
sequential steps of synaptic vesicle docking, activation and fusion. Cell 75, 409-418. 
 
Stenmark, H. (2009). Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell 
Biol 10, 513-525. 
 
Stow, J. L., Mander’son, A. P. and Murray, R. Z. (2006). SNAREing immunity: the role 
of SNAREs in the immune system. Nat Rev Immunol 6, 919-929. 
 
Sutton, R. B., Fasshauer, D., Jahn, R. and Brunger, A. T. (1998). Crystal structure of a 
SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395, 347-
353. 
 
Takada, K. and Jameson, S. C. (2009). Naïve T cell homeostasis: from awareness of 
space to a sense of place. Nat Rev Immunol 9, 823-832  
---------- Literature ---------- 
- 82 - 
 
Tanchot, B. R. (1995). The peripheral T cell repertoire: independent homeostatic 
regulation of virgin and activated CD8 T cells. Eur J lmmunol. 25:2127-36. 
 
Tang, B. L., Low, D. Y. and Hong, W. (1998a). Syntaxin 11: a member of the Syntaxin 
family without a carboxyl terminal transmembrane domain. Biochem Biophys Res 
Commun 245, 627-632. 
 
Tang, B. L., Low, D. Y., Lee, S. S., Tan, A. E. and Hong, W. (1998b). Molecular cloning 
and localization of human Syntaxin 16, a member of the Syntaxin family of SNARE 
proteins. Biochem Biophys Res Commun 242, 673-679. 
 
Teng, F. Y., Wang, Y. and Tang, B. L. (2001). The Syntaxins. Genome Biol, REVIEWS 
3012. 
 
Tipping, P. G. (2006). Toll-Like Receptors: The Interface between Innate and Adaptive 
Immunity. Journal of the American Society of Nephrology 7, 1769-1771. 
 
Valdez, A. C., Cabaniols, J. P., Brown, M. J. and Roche, P. A. (1999). Syntaxin 11 is 
associated with SNAP-23 on late endosomes and the trans-Golgi network. J Cell Sci 
112, 845-854. 
 
Voskoboinik, I., Smyth, M. J. and Trapani, J. A. (2006). Perforin-mediated target-cell 
death and immune homeostasis. Nat Rev Immunol 6, 940-952. 
 
Wang, Y., Tai, G., Lu, L., Johannes, L., Hong, W. and Tang, B. L. (2005). Trans-Golgi 
network Syntaxin 10 functions distinctly from Syntaxins 6 and 16. Mol Membr Biol 22, 
313-325. 
 
Wong, S. H., Xu, Y., Zhang, T. and Hong, W. (1998). Syntaxin 7, a novel Syntaxin 
member associated with the early endosomal compartment. J Biol Chem 273, 375-380. 
 
---------- Literature ---------- 
- 83 - 
 
Xie, L. X., de la Iglesia-Vicente, J., Fang, Y. X. and Mollinedo, F. (2009). Expression 
and subcellular localization of Syntaxin 11 in human neutrophils. Inflamm Res 58, 407-
412. 
 
Ye, S., Karim, Z. A., Al Hawas, R., Pessin, J. E., Filipovich, A. H. and Whiteheart, S. W. 
(2012.) Syntaxin-11, but not Syntaxin-2 or Syntaxin-4, is required for platelet secretion. 
Blood 120, 2484-2492. 
 
Zhang, B. and Ginsburg, D., (2003). Getting secretory granules ready for prime time. 
Cell 115, 372-373. 
 
Zhang, K., Filipovich, A. H., Johnson, J., Marsh, R. A. and Villanueva, J. (1993). 
Hemophagocytic Lymphohistiocytosis, Familial. Bookshelf ID: NBK1444 
 
Zhang, S., Ma, D., Wang, X., Celkan, T., Nordenskjold, M., Henter, J. I., Fadeel, B. and 
Zheng, C. (2008). Syntaxin-11 is expressed in primary human monocytes/macrophages 
and acts as a negative regulator of macrophage engulfment of apoptotic cells and IgG-
opsonized target cells. Br J Haematol 142, 469-479. 
 
Zhizhuo, H., Junmei, X., Yuelin, S., Qiang, Q., Chunyan, L., Zhengde, X. and Kunling, 
S. (2012). Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP and ITK gene 
mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic 
lymphohistiocytosis. Pediatr Blood Cancer 58, 410-414. 
 
Zur Stadt, U., Beutel, K., Kolberg, S., Schneppenheim, R., Kabisch, H., Janka, G. and 
Hennies, H. C. (2006). Mutation spectrum in children with primary hemophagocytic 
lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11 and 
RAB27A. Hum Mutat 27, 62-68. 
 
 
 
---------- Literature ---------- 
- 84 - 
 
zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauss, J., Kasper, 
B., Nurnberg, G., Becker, C., et al. (2009). Familial hemophagocytic lymphohistiocytosis 
type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to Syntaxin 
11. Am J Hum Genet 85, 482-492. 
 
zur Stadt, U., Schmidt, S., Kasper, B., Beutel, K., Diler, A. S., Henter, J. I., Kabisch, H., 
Schneppenheim, R., Nurnberg, P., Janka, G. and Hennies, H. C. (2005). Linkage of 
familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and 
identification of mutations in Syntaxin 11. Hum Mol Genet 14, 827-834. 
 
---------- Curriculum vitae ---------- 
- 85 - 
 
8. CURRICULUM VITAE 
Personal information 
Name: Mahantappa Halimani 
Date of birth: 1st June 1983 
Place of birth: Chinamagera, India 
Marital status: Single 
 
Education 
2005     Master degree in Biotechnology at Gulbarga University, India 
2003     Bachelor degree in Chemistry Botany and Zoology at Gulbarga University,  
           India 
 
Research experience  
            
          
 
  
July 2009-current PhD at University of Saarland, under the supervision of  
Prof Jens Rettig, Physiologisches Institut. 
2007-2009 Research associate CSIR Lab Institute of Genomics and 
Integrative Biology (IGIB), Delhi, India 
2005-2007 Trainee and Quality Control manager at Cryostem Cell Pvt Ltd, 
Bangalore, India. 
---------- Publications ---------- 
- 86 - 
 
9. PUBLICATIONS 
Published: 
1. Matti U*, Pattu V*, Halimani M, Schirra C, Krause E, Liu Y, Weins L, Chang HF, 
Guzman R, Olausson J, Freichel M, Schmitz F, Pasche M, Becherer U, Bruns D & 
Rettig J. Synaptobrevin2 is the v-SNARE required for cytotoxic T lymphocyte lytic 
granule fusion. Nat. Commun. 4: 1439 doi: 10.1038/ncomms2467 (2013). PMID: 
23385584 
        *equal contribution 
 
2. Bargaje R, Gupta S, Sarkeshik A, Park R, Xu T, Sarkar M, Halimani M, Roy SS, 
Yates J, Pillai B. Identification of Novel Targets for miR-29a Using miRNA 
Proteomics. PLoS One. 2012; 7(8):e43243. Epub 2012 Aug 27.PMID: 22952654 
 
3. Pattu V*, Qu B*, Weins L, Shruthi SB, Marshall M, Halimani M, Schwarz EC, 
Rettig J, Hoth M. SNARE protein expression and localization in human cytotoxic T 
lymphocytes. European Journal of Immunology. 2012 Feb; 42(2):470-475. PMID: 
22120889 
        *equal contribution 
 
4. Halimani M, Chandran P, Kashyap S, Jadhav V. M, Prasad LV, Hotha S, Maiti S. 
Dendritic Effect of Ligand-Coated Nanoparticles: Enhanced Apoptotic Activity of 
Silica−Berberine Nanoconjugates.  
        Langmuir 2009 25 (4), 2339-2347. PMID: 19146398. 
 
5. Ghosh T, Soni K, Scaria V, Halimani M, Chaitali B, Pillai B.MicroRNA mediated up 
regulation of an alternatively polyadenylated variant of the mouse cytoplasmic ß-
actin gene. Nucleic Acids Res (2008).1-15. PMID: 18835850. 
 
6. Halimani M, Banik A, Shivshankar J, Rao S G A. The Stem Cells in the Umbilical 
cord blood is not related to the volume and nucleated cell count. Indian J 
Biotechnology. 2008 (7), 547-549 
 
---------- Publications ---------- 
- 87 - 
 
Communicated: 
1. Halimani M, Pattu V, Chang HF, Matti U, Becherer U, Krause E, Hoth M & Rettig 
J. Syntaxin11 serves as a t-SNARE for the final fusion step of lytic granules in 
human cytotoxic T lymphocytes. Feb 2013, Under Revision in Blood. 
 
2. Hugo S, Dembla D, Peglow M, Halimani M, Matti U, Rieger H, Rettig J, Becherer 
U. Deciphering dead-end docking of large dense core vesicles in chromaffin cells. 
In preparation for submission to JBC in Feb 2013. 
 
3. Marshall MR, Pattu V, Halimani M, Maier-Peuschel, Tschernig T, M, Hoth M, 
Rettig J. VAMP8 is the v-SNARE mediating recycling endosome fusion in 
CD3/CD28 mediated granule exocytosis of T lymphocytes. In submission to Nat 
Immunology. 
 
4. Dudenhöffer-Pfeifer M, Marshall MR, Halimani M, Schirra C, Stevens D, Sester M, 
Planz O, , Hoth M, Krause E, Rettig J. Different Munc13 isoforms function in lytic 
granule release from cytotoxic T lymphocytes. Revise and resubmit in Traffic 
Journal. 
 
 
 
 
 
 
